WO2013066050A1 - Composition for preventing raised blood pressure comprising salicornia herbacea and garlic, and production method therefor - Google Patents
Composition for preventing raised blood pressure comprising salicornia herbacea and garlic, and production method therefor Download PDFInfo
- Publication number
- WO2013066050A1 WO2013066050A1 PCT/KR2012/009072 KR2012009072W WO2013066050A1 WO 2013066050 A1 WO2013066050 A1 WO 2013066050A1 KR 2012009072 W KR2012009072 W KR 2012009072W WO 2013066050 A1 WO2013066050 A1 WO 2013066050A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- garlic
- salt
- seaweed
- blood pressure
- hot water
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/10—Natural spices, flavouring agents or condiments; Extracts thereof
- A23L27/105—Natural spices, flavouring agents or condiments; Extracts thereof obtained from liliaceae, e.g. onions, garlic
Definitions
- the present invention relates to a composition having a blood pressure increase preventing effect and a method for producing the same.
- Hypertension refers to abnormally elevated blood pressure and is one of the main causes of aggravating cardiovascular disease and increasing mortality. If hypertension is defined as hypertension when the systolic blood pressure is 140 mmHg or more and the diastolic blood pressure is 90 mmHg or more.
- Types of hypertension include essential hypertension and secondary hypertension. Among them, essential hypertension is unknown hypertension and accounts for 80% to 90% of hypertensive patients.
- the sensitivity is accounted for 30% to 50% of patients with essential hypertension, and 10% of blood pressure is known to increase with high salt (200 to 250 mEq Na + / day) for one week.
- high salt 200 to 250 mEq Na + / day
- the WHO / ISH recommends that adults consume less than 5 g of salt daily, while the Japanese Society of Hypertension recommends less than 7 g.
- Salt which is the main ingredient that causes blood pressure rise, has a negative effect on health, causing changes in blood vessel structure and oxidative stress, causing endothelial dysfunction and cardiovascular dysfunction, which increases blood pressure.
- Salts used in blood pressure studies in animal experiments were salts with few minerals, and very little research was conducted on salts containing a large amount of minerals.
- minerals such as Na, K, Ca, and Mg are known to suppress blood pressure rise.
- K increases the production of NO to relax the endothelial blood vessels
- Ca affects the contraction and relaxation of muscles and blood vessels
- blood pressure is reduced by relaxing the blood vessels.
- Mg is known to affect the blood pressure by causing changes in NO production and vascular structure.
- Salts can be broadly classified into rock salt, refined salt, recontaminated salt and sun salt, and are known to have different mineral contents depending on the type of salt.
- rock salts and refined salts consumed by people all over the world have NaCl content of more than 99%, while minerals such as K, Ca, and Mg have almost no minerals, but tidal flat salt produced in Korea has 85% NaCl content, whereas K, The content of minerals such as Ca and Mg was very high.
- IRS-1 insulin receptor substrate-1
- salts rich in minerals have been shown to reduce blood pressure and reduce oxidative damage in salt and rats compared to salts with little or no minerals. Therefore, minerals such as K, Ca, and Mg except Na have a positive effect on suppressing blood pressure rise or lowering insulin resistance.
- the present invention is to improve the problems of the prior art as described above, to prevent or improve the composition of blood pressure increase, specifically to taste salty, while being able to replace salt, unlike salt to prevent or improve blood pressure rise It is an object of the present invention to provide a salt replacement composition and a method for producing the same.
- the food additive composition may have an effect of preventing, suppressing or improving blood pressure.
- the salt substitute food additive composition may be a salt substitute food additive composition having a high blood pressure suppressing or preventing effect including hot water extracts of the mixture of seaweed and garlic as an active ingredient.
- the salt substitute food additive composition is dried crushed leaf and stem of the seaweed and ground crushed seaweed ground and garlic based on the weight of 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) Mixing at a content ratio; Hot water extraction for 2 hours to 12 hours at 100 to 175 °C and 10 atm (atm) to 17 atm (atm) of the mixture of the seaweed and garlic mixture to prepare a hot water extract and garlic and hot water extract It may be a salt substitute food additive composition having a high blood pressure inhibiting or preventing effect that is prepared by the method comprising the step of spray drying to dry.
- the present invention comprises the step of mixing the leaves and stems of the vinegar and dried and ground crushed seaweed grinding and garlic by 9: 1 (seaweed: garlic) by weight; Blood pressure comprising the step of producing hot water extract and the hot water extract garlic and garlic hot water extract for 5 hours under conditions of 130 °C and 15 atm (atm) and spray drying the water and garlic hot water extract It may be a method of preparing a seaweed garlic salt having a synergistic inhibitory or preventive effect.
- the composition prepared by using the seaweed and garlic of the present invention that is, the salt prepared by using the seaweed and garlic, has an excellent antihypertensive effect while having NaCl content equivalent to that of a natural salt known to have superior antihypertensive activity than ordinary salts. It was confirmed that.
- the seaweed garlic salt prepared by the preparation method of the present invention has angiotensin converting enzyme inhibitory activity, which is a blood pressure increase factor, and confirmed by using salty rats, as a result, almost completely suppresses the blood pressure increase resulting from salt intake. Rather, because it reduces oxidative stress, it was confirmed that the blood pressure increase caused by salt intake could be suppressed.
- FIG. 1 is a flow chart schematically showing a method of manufacturing a seaweed garlic salt, which is a functional salt having a blood pressure increase suppressing effect according to an embodiment of the present invention.
- Figure 2 compares the effect of inhibiting the increase in systolic blood pressure from salt intake during dietary preparation of seaweed garlic salt when saltwort garlic salt is used in salt-infested rats according to an embodiment of the present invention. It is a graph shown.
- Figure 3 compares the effect of inhibiting the increase in diastolic blood pressure from salt intake during dietary preparation of seaweed garlic salt in comparison with the salt salt group and sea salt diet group It is a graph shown.
- Figure 4 is a graph showing the angiotensin converting enzyme activity of the blood pressure-enhancing enzymes in the plasma of the saltwort garlic salt group when the saltwort garlic salt according to an embodiment of the present invention in salty rats.
- Figure 5 is to increase the expression level of vascular endothelial growth factor (VEGF) involved in lowering blood pressure by increasing the amount of NO production in the kidney when the seaweed garlic salt according to an embodiment of the present invention in salty rats It shows the effect.
- VEGF vascular endothelial growth factor
- RhoA expression involved in increasing the blood pressure by increasing the vascular tone by inhibiting myosin phosphatase in the kidney when the seaweed garlic salt is used in salty mice according to an embodiment of the present invention. It is a graph showing the effect of lowering the amount.
- FIG. 7 is a graph showing the antioxidant activity from the results showing that the seaweed garlic salt diet reduces lipid peroxides in the plasma when the seaweed garlic salt according to an embodiment of the present invention is used in salty rats.
- the seaweed used in the present invention was grown in Jeollanam-do, Jeollanam-do, and it was used after it was naturally dried after harvesting it in 2008.
- Garlic used in the present invention was used in 2008 purchased in Shinan-gun, Jeollanam-do.
- a method of preparing seaweed garlic salt using seaweed and garlic is as shown in FIG. 1. More specifically, 1,000 g of dried dried seaweed, 900 g of dried seaweed and 100 g of dried garlic or 700 g of dried seaweed, and 300 g of dried garlic, respectively, were mixed, and then 10 L of water was added thereto to the high-pressure extractor. Put in. The dried seaweed and fresh garlic mixture were extracted with high-pressure hot water for 5 hours at a temperature of 130 ° C. and a pressure of 15 atmospheres (atm), followed by filtration to obtain a high-pressure hot water extract. The obtained seaweed garlic high pressure hot water extract was spray-dried using a spray dryer to prepare seaweed plant salt (GG).
- GG seaweed plant salt
- the pH of the seaweed garlic salt was measured by using a pH meter after the sample concentration was a 10% solution, and salinity was measured by the Mohr method.
- the pH of the saltwort salt prepared from the high-pressure hot water extract of seaweed was pH 6.54
- the pH of the seaweed garlic salt prepared from the high-pressure hot water extract extracted with high-pressure hot water with garlic was pH 4.34 or pH 4.48. It was.
- the angiotensin converting enzyme coenzyme liquid was obtained by centrifuging at 4000 degreeC and 4 degreeC for 40 minutes.
- the angiotensin converting enzyme inhibitory activity was added to 100 ⁇ l of 0.1 M sodium borate buffer (pH 8.3) and 50 ⁇ l of the obtained angiotensin converting enzyme coenzyme solution to 50 ⁇ l of the 1% sample prepared using each salt. After preliminary reaction for 5 minutes at 50 ° C., 50 ⁇ l of substrate prepared by adding 25 mg of hippuryl histidyl leucine (HHL) to 5 ml of 0.1 M sodium borate buffer (pH 8.3) containing 0.3 M NaCl was added for 30 minutes at 37 ° C. Reacted.
- HHL hippuryl histidyl leucine
- angiotensin converting enzyme inhibitory activity was calculated using the following formula.
- both the seaweed salt and seaweed garlic salt obtained in Example 1 showed angiotensin converting enzyme inhibitory activity.
- garlic-containing garlic salts had higher angiotensin-converting enzyme inhibitory activity than that of salt-containing salts, and the more garlic was added, the higher the inhibitory activity was.
- the amount of garlic added increased, the salinity was lowered, and the garlic aroma was too strong, suggesting a bad flavor. Therefore, it was judged that it is suitable to mix 100 g of garlic with 900 g of seaweed during the preparation of seaweed garlic salt.
- Example 3 the anti-hypertensive activity was confirmed by using angiotensin converting enzyme inhibitory activity, and when the saltwort salt and the seaweed garlic salt prepared in Example 1 were used in salty rats, whether the blood pressure increase resulting from salt ingestion was suppressed. It was confirmed.
- the experimental animals used in the present invention were purchased from Daolol Science Co., South Korea, 8-week-old male Dahl salt-sensitive rats, their average weight was 390 ⁇ 20 g.
- mice were prepared by breeding general feed on the basis of AIN-93G, and were bred under conditions of temperature of 20 ° C., humidity of 50% to 60% relative humidity, and lighting conditions of 12 hours of lighting cycle. Free to eat.
- the experimental group was prepared to meet the 3% sodium chloride content in each treatment group.
- the prepared feed was adjusted in consideration of the NaCl content of the seaweed salt and seaweed garlic salt identified in Example 2, the dose of the seaweed salt and seaweed garlic salt. Specifically, feeds containing 3% sun salt (w / w, sun salt group), 2% sun salt and about 2% sea salt, and diets containing 2% sun salt and about 2% seaweed garlic salt respectively.
- a high salt diet was prepared using (Soncho garlic salt group).
- the blood pressure measurement used for assaying the effect of inhibiting the increase in blood pressure of seaweed garlic salt using the experimental animal was used by applying the tail-cuff method.
- the rats when the blood pressure is measured, the rats are put in a narrow cage and take a long time to stabilize, and also a large amount of stress from the outside is provided by installing a measuring device in the tail, so that the deviation of the analyzed blood pressure value is large.
- the systolic system can be inserted at the beginning of the experiment using a PA-C40 Transmitter (Data Sciences International: DSI, USA), which inserts a blood pressure sensor into the femoral artery of the animal and freely measures blood pressure remotely. And diastolic blood pressure were measured.
- the blood pressure measurement results are shown in FIGS. 2 and 3.
- systolic blood pressure is shown in FIG. 2.
- the SUN diet group and the seaweed salt diet group continuously increased systolic blood pressure during the diet period. This is consistent with the results of elevated blood pressure when salted rats ingest salt.
- the hamcho salt diet group showed a lower rise than the sun salt diet group.
- the seaweed garlic salt group showed a systolic blood pressure increase up to 6 days after the diet, but it did not increase during the diet period.
- the hamcho garlic salt group maintained a lower systolic blood pressure than the hamcho salt diet group and sun salt diet group, and showed significantly different values from the 18th day of diet, and showed a significant difference after 4 weeks of diet.
- Excess salt intake has been reported to have a direct impact on diseases associated with metabolic syndrome, such as hypertension and diabetes.
- the salinary garlic salt had little increase in systolic blood pressure unlike the salt rich salt, that is, the salt of sea salt, in salted rats, which means that the antihypertensive activity of seaweed garlic salt was remarkably superior to previously reported data. It can be interpreted as.
- diastolic blood pressure is shown in FIG.
- the diastolic blood pressure of each diet group showed a similar tendency to systolic blood pressure results during the diet.
- the SPA and Hamcho salt diets showed a steady increase in diastolic blood pressure during the diet
- the Shamcho salt diet group showed a lower rise than the SUN diet group, but there was no significant difference between the groups.
- the hamcho garlic salt group showed that the diastolic blood pressure increased until the 6th day of diet, but the systolic blood pressure was shown to be consistent with the systolic blood pressure result. In other words, as with systolic blood pressure results, seaweed garlic salt did not increase diastolic blood pressure.
- the seaweed garlic salt was judged to have an excellent effect of suppressing blood pressure increase, unlike conventional salts, such as sun salt or seaweed salt.
- Blood obtained in the animal experiment in Example 4 was collected and the angiotensin converting enzyme activity of the seaweed garlic salt diet group was measured.
- the experimental animals were sacrificed by cervical separation after fasting 12 hours before sacrifice and anesthesia with ether.
- the animals were opened from the abdomen to the thorax and blood was collected directly from the heart with the heart rate maintained.
- the liver, adipose and muscle tissues were then separated and washed with physiological saline cooled by ice and stored at -70 ° C until use for analysis.
- Angiotensin converting enzyme activity of all diets was obtained by dissolving 5 mM substrate (Hip-His-Leu, 150 ⁇ L) dissolved in 100 mM sodium borate buffer solution (pH 8.3) containing 300 mM NaCl substrate in serum (50 ⁇ L). The mixture was added and mixed, followed by reaction at 37 ° C. for 45 minutes. 200 ⁇ L of 2N HCl was added to the reaction solution to stop the enzyme reaction, and then 2.0 mL of ethyl acetate was distributed thereto. The obtained ethyl acetate was centrifuged at 1000 x g for 10 minutes, and then 1.5 mL of the supernatant was transferred to a glass tube and concentrated under reduced pressure at room temperature. 1 mL of distilled water was added to the concentrated product, dissolved, and the absorbance was measured at 228 nm.
- the angiotensin converting enzyme activity of each diet group was confirmed by converting the absorbance value into the amount produced by the hypric acid using a calibration curve of the standard solution (hippuric acid). The confirmed result is shown in FIG. 4.
- the angiotensin converting enzyme activity in the plasma of the saltwort group was not significantly different between the salt group, but showed a slightly lower inhibitory activity, showing the same tendency as the systolic and diastolic blood pressure results.
- hamcho garlic salt group showed significantly lower angiotensin converting enzyme activity than hamcho salt diet group and sun salt diet group.
- the renin-angiotensin-aldosterone system is an important factor in controlling the parallel between blood pressure and water in our bodies.
- renin when the body lacks water, renin is released from the kidneys, and then angiotensin produced by the liver constricts blood vessels.
- aldosterone hormone sends water and sodium from the kidneys to the blood to raise blood pressure.
- the small amount of angiotensin converting enzyme expression can be interpreted as a low blood pressure in the body.
- seaweed garlic salt did not increase blood pressure and had low angiotensin converting enzyme activity even when ingested into salty rats whose blood pressure increased due to salt intake.
- VEGF vascular endothelial growth factor
- RhoA ras homolog gene family member A
- Example 4 4 g of the adipose tissue of each dietary group obtained in Example 5 from the experimental animal bred in Example 4 was placed in a glass bottle, 1% Triton X-100, 50 mM HEPES (pH 7.4), 100 mM Add 2 ml of homogenized buffer consisting of sodium pyrophosphate, 10 mM NF, 10 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 1 / ml pepstatin, 1 / ml leupeptin, 10 mM Na 3 VO 4 and 0.1 mg / ml aprotinin, and then immediately PT1200E, Kinematicca AG, Switzerland).
- homogenized buffer consisting of sodium pyrophosphate, 10 mM NF, 10 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 1 / ml pepstatin, 1 / ml le
- the membrane washed repeatedly three times with TBST solution for 5 minutes was put in a lypophilized buffer containing primary antibodies (Anti-VEGF and RhoA, Santa Cruz Biotechnology, Korea) and reacted with gentle stirring at room temperature. After completion of the primary antibody reaction, the membrane was washed three times with TBST solution three times, and then a secondary antibody (horseradish peroxidase (HRP) -conjugated goat anti-rabbit immunoglobin G) was added and reacted at room temperature for 1 hour. The washed membrane was then reacted with an enhanced chemiluminescence (ECL) solution containing luminol. 5 and 6 show photographs of the result of the reaction.
- HRP horseradish peroxidase
- the sun salt diet group containing only sun salt showed the lowest expression level of VEGF, and both the seaweed salt diet group and the hamcho garlic salt group showed higher expression levels than the sun salt diet group.
- the expression levels of VEGF between the seaweed salt diet group and the seaweed garlic salt diet group were almost similar.
- VEGF is a protein that induces NO production by expressing NO synthase and is one of the factors controlling blood pressure. It is known that the higher the expression level of this factor, the lower the blood pressure by increasing the NO production. Therefore, it was confirmed that seaweed garlic salt lowered blood pressure by increasing the amount of NO produced compared to sun salt.
- the expression level of RhoA which regulates muscle relaxation and contraction, showed a tendency opposite to that of VEGF expression. That is, the sun salt group showed the highest expression level of RhoA, and the seaweed salt and seaweed garlic salt group showed the low expression level. In addition, the two seaweed garlic diet groups showed lower RhoA expression than the seaweed salt diet group.
- seaweed garlic salt exhibited a lower RhoA expression level than the sun salt or seaweed salt means that the blood vessel tension was reduced by inhibiting the RhoA expression, thereby suppressing the increase in blood pressure. Therefore, it was confirmed that the seaweed garlic salt has an effect of suppressing blood pressure increase more than that of seaweed salt or sun salt.
- Lipid peroxide content in the plasma obtained in the animal experiment of Example 5 was measured by the TBARS method.
- 0.1 mL of plasma was mixed with 0.5 mL of 0.6 M HCl of 20% trichloroacetic acid and 0.3 mL of 1 M NaOH solution of 0.67% thiobarbituric acid, followed by reaction at 95 ° C. for 20 minutes.
- the reaction solution was cooled and then partitioned into 0.8 mL of butanol and centrifuged for 10 minutes at 1500 ⁇ g.
- the absorbance of the obtained butanol layer was measured at 532 nm and these absorbance values were converted to lipid peroxide content in plasma using the standard curvature of prepared standard solution (malonaldehyde, MDA). The result obtained by the said conversion is shown in FIG.
- the lipid peroxide oxide (malondialdehyde, MDA) content in plasma was the highest in the salt group, and the seaweed salt group and the hamcho garlic salt group had a lower MDA content in blood than the salt group.
- the seaweed garlic diet group showed lower contents than the seaweed salt diet group.
- the saltwort salt prepared using the seaweed further reduces oxidative stress.
- the seaweed garlic salt prepared by mixing the seaweed and garlic was determined to more strongly inhibit the production of lipid peroxides in the blood. Therefore, the intake of seaweed garlic salt was found to be effective in reducing the oxidative stress from salt intake in the body.
- the present invention relates to a blood pressure increase prevention composition
- a blood pressure increase prevention composition comprising an active ingredient of seaweed and garlic.
- the present inventors have no side effects, and while studying antihypertensive substances derived from natural substances, which have no problems with resistance or stability even after long-term use, while increasing the blood pressure while ingesting salt, that is, NaCl, which causes an increase in existing blood pressure
- the study was conducted to determine if it could help to control the diet of hypertensive patients.
- salt means all types of salt that can be used for food, not for industrial purposes, and include salt, rock salt, flower salt, roasted salt, bamboo salt, refined salt, reconstituted salt, molten salt, refined salt or processed salt, and the like. do.
- the natural salt refers to an unprocessed salt made by concentrating seawater by evaporating water using natural forces such as wind and sunlight after introducing seawater or seawater into a reservoir or salt field, and having coarse and translucent hexagons. Has the characteristic of having a crystal.
- the sun salt is called mineral salt because it is rich in many minerals (minerals) such as calcium, magnesium, zinc, potassium, and iron.
- the natural salt produced in our country, specifically, the natural salt produced in Jeollanam-do is preferred because it is rich in minerals.
- Salicornia herbacea L., glasswort is a herbaceous perennial herbaceous herbaceous plant, which is also called as a stalk in Korea, and is one of the salt plants that grow wild on the west coast and south coast of Korea along with turkey and seaweed herbs. Unlike other plants, this plant is able to grow in high salinity seawater and contains excessive amounts of minerals such as Ca, K, Mg, Fe, and Zn along with NaCl of about 15%.
- garlic is a perennial plant belonging to the genus Lilliaceae, is a representative Allium plant.
- Garlic has been widely used as a seasoning to enhance the flavor of food and has been found to be antibacterial, anti-cancer effect, liver protection and liver disease treatment effect.
- Alliin (S-allyl-L-cysteinesulfoxide) contained in the garlic is known as a representative active ingredient.
- the seaweed garlic salt is prepared by the manufacturing method of the present invention, and the main ingredients of seaweed and garlic, and contains a large amount of sodium chloride (NaCl), can be used as a salt substitute, blood pressure by sodium chloride intake It means that the anti-hypertensive effect, that is, a salt substitute food additive having an antihypertensive effect, suppression or prevention effect, can be suppressed.
- NaCl sodium chloride
- a functional food is a biological defense rhythm control or disease prevention of a food group or a food composition that has added value to the food by using physical, biochemical, or biotechnological techniques to act and express the function of the food for a specific purpose.
- the present invention relates to a food additive composition
- a food additive composition comprising a hamcho and garlic extract as an active ingredient.
- the seaweed and garlic extract may be a plant extract using an extracting solvent, an extract obtained by an extracting solvent, or a fraction obtained by a fractionating solvent.
- the extract may be at least one selected from the group consisting of stems, leaves, roots, flowers, and fruits, preferably at the ground portion, and more preferably at least one selected from the group consisting of leaves and stems.
- the garlic to be extracted may be at least one selected from the group consisting of stems, leaves, roots, flowers, and fruits, and may preferably be a fruit.
- the extraction solvent may be water, 50% to 100% methanol, alcohol having 1 to 4 carbon atoms such as ethanol, polar solvent such as ethyl acetate, organic solvent such as a non-polar solvent of hexane or dichloromethane, mixed solvent thereof, , Preferably water or alcohol having 1 to 4 carbon atoms such as methanol, ethanol of 50% to 100%, more preferably water.
- Hamcho extract of the present invention may be prepared according to the conventional method for producing a plant extract, specifically may be cold extraction, hot extraction or heat extraction, etc., may be used a conventional extraction device, ultrasonic grinding extractor or fractionator It may be preferably a hot water extraction method.
- the prepared extract can then be filtered or concentrated or dried to remove the solvent, it can be carried out both filtration, concentration and drying.
- the filtration may be performed using a filter paper or a reduced pressure filter
- the concentration may be concentrated under reduced pressure using a reduced pressure concentrator, for example, a rotary evaporator
- the drying may be performed by, for example, spray drying.
- Food additive composition comprising the extract and the garlic extract as an active ingredient may be a food additive composition for salt replacement.
- the salt substitute food additive composition of the present invention may be a seaweed garlic salt, preferably may be a seaweed garlic salt prepared by the production method of the present invention.
- the production method of the present invention comprises the steps of mixing the seaweed and garlic; It may be a method of manufacturing a seaweed garlic salt comprising the step of extracting the hot water and the mixture of the seaweed and garlic and drying the hot water extract of the seaweed and garlic.
- the seaweed and garlic may be performed by mixing the seaweed and garlic.
- the grasswort may be a ground and dried leaf and stem of the grasswort and dried.
- the garlic may be a fruit of garlic or a pulverized product of the fruit.
- the mixing ratio of the seaweed and garlic is 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) or 9.5: It may be mixed in a ratio of 0.5 (seaweed: garlic) to 8: 2 (seaweed: garlic) or 9: 1 (seaweed: garlic).
- the hydrothermal extraction of the mixture of seaweed and garlic may be performed by adding water to the grasswort garlic mixture and adding 70 to 200 ° C or 100 to 175 ° C or 120 to 150 ° C and 5 atm to 20 atm or 10 atm ( atm) to 17 atm or 15 atm for 1 hour to 24 hours or 2 hours to 12 hours or 4 hours to 7 hours.
- the extracting of hot water may further include obtaining a extract by filtering the crude extract obtained after extraction by the above method or obtaining a concentrate by concentrating the extract under reduced pressure.
- Drying the seaweed and garlic hot water extract may be performed by drying the seaweed and garlic hot water extract.
- the drying method may be a method of removing moisture of the seaweed and garlic hot water extract, for example, may be a method of preparing in powder form through a spray drying method.
- angiotensin converting enzymes act on four types of AT receptors present in the adrenal glands, vascular smooth muscle cells, kidneys, and the heart, and these include vasoconstriction, aldosterone, and vasopressin. It can cause various lesions in the cardiovascular, renal and central nerve areas by inducing release, absorption of sodium in the tubules, and decreased blood flow to the kidneys. Therefore, inhibitors of angiotensin converting enzyme or angiotensin converting enzyme inhibitor (ACE inhibitor) It can treat, ameliorate or prevent cardiovascular diseases such as heart disease, arteriosclerosis, or cerebral hemorrhage.
- ACE inhibitor angiotensin converting enzyme inhibitor
- Blood pressure in the present invention refers to the force that blood exerts on the walls of blood vessels. When reading blood pressure, it is divided into systolic blood pressure (highest blood pressure) and diastolic blood pressure (lowest blood pressure).
- systolic blood pressure is the pressure exerted on blood vessels as the heart contracts and releases blood
- diastolic blood pressure is the pressure the blood vessel receives when the heart receives blood as it expands (relaxes).
- the hypertension is a disease in which systolic blood pressure is 140 mmHg or more or diastolic blood pressure is 90 mmHg or more in adults over 18 years of age, and the cause is not found in cases of essential (primary) hypertension and the cause of which hypertension occurs. About 95% of all hypertensive patients are essential hypertension. Diseases caused by the hypertension include hypertensive heart disease (hypertensive heart disease).
- Food additive composition containing the seaweed and garlic extract as an active ingredient or seaweed garlic salt prepared by the manufacturing method of the present invention may inhibit angiotensin converting enzyme, and has an ability to lower blood pressure, thereby treating, preventing or improving hypertension. It can be used as a composition.
- the hypertension is a blood vessel-related disease, and may be arterial hypertension with high arterial blood pressure.
- the hypertension may cause arteriosclerosis or hypertensive heart disease.
- angiotensin converting enzymes are one of the dicarboxyl peptides found in the proximal tubules of the blood vessels and kidneys, endothelial, heart, lung, activated macrophages and brain tissues.
- Vasopressin release, the absorption of sodium in the tubules and decreased blood flow to the kidney have been reported to lead to various lesions in the cardiovascular, renal and central nervous areas.
- angiotensin converting enzyme inhibitor or angiotensin converting enzyme inhibitor is reported to be able to treat or prevent cardiovascular diseases such as hypertension, heart disease, arteriosclerosis, or cerebral hemorrhage or kidney disease, and specifically, clinical studies In clinical trials, angiotensin converting enzyme inhibitors have been reported to effectively reduce hypertension, chronic kidney disease, atherosclerosis, heart attacks and death.
- Food additive composition containing the seaweed and garlic extract as an active ingredient or seaweed garlic salt prepared by the manufacturing method of the present invention effectively inhibits angiotensin converting enzyme, and as a result of animal experiments confirmed that blood pressure lowering ability, hypertension and It is effective in treating, preventing or ameliorating cardiovascular diseases such as heart disease, arteriosclerosis, or cerebral hemorrhage.
- Food additive composition comprising the extract of the seaweed and garlic as an active ingredient, in particular the salt substitute food additive composition containing the extract as an active ingredient effectively inhibits angiotensin converting enzyme, and confirmed through animal experiments It has an antihypertensive ability and an antioxidant ability, and thus has an antihypertensive effect, that is, an antihypertensive effect, a prophylactic or inhibitory effect.
- Food additive composition comprising the extract and the garlic extract of the present invention as an active ingredient may comprise the active ingredient in an amount of 0.001 to 99.99% by weight, preferably 0.1 to 99% by weight based on the total weight of the composition.
- the food means a natural product or a processed product containing one or more nutrients, and preferably means a state in which it can be directly eaten through some processing process.
- the food additive means a substance which improves the quality of the food by adding or mixing the food for the purpose of manufacturing, processing, or preserving the food, and used for food in addition to the raw materials or the main ingredient in the manufacturing, processing or storage of the food. It is a concept that includes the substance to be added and the additives prescribed in Article 2 (3) of the Food Sanitation Act.
- the food additive may be used for the purpose of imparting saltiness to food, it may be used as a seasoning for replacing salt, soy sauce or miso in this sense, and to suppress, improve or prevent diabetes-induced effects such as salt intake. Since it is intended to be, it may preferably be a salt substitute food additive.
- the food additive may be a salt substitute food additive.
- the food additives impart salty taste, such as salt, angiotensin converting enzyme inhibitory ability and blood pressure lowering ability are recognized, and in this aspect, the food additives may correspond to functional foods.
- the food additive may further include food acceptable food additives, and may further include appropriate carriers, excipients and diluents commonly used in the preparation of food additives or functional foods.
- the carriers, excipients and diluents can be used independently or in combination.
- the proportion of auxiliary additives additionally included such carriers, excipients and diluents is not so critical, but may be selected from 0 to 20000 parts by weight per 100 parts by weight of the active ingredient of the present invention.
- the composition of the present invention inhibits angiotensin-converting enzymes unlike the purified salts that are mainly used for edible blood pressure, that is, conventionally found to be capable of causing high blood pressure, and confirmed by experimental animals. It has been confirmed that the inhibitory ability can be useful in patients with hypertension or in individuals at risk of these diseases, and particularly, for the purpose of imparting salty taste to the patient or the food ingested by the individual. .
- the present invention provides a method for producing a seaweed garlic salt that has an antihypertensive effect, that is, hypertension improvement, prevention or inhibition.
- the production method of the present invention comprises the steps of mixing the seaweed and garlic; It may be a method of manufacturing a seaweed garlic salt comprising the step of extracting the hot water and the mixture of the seaweed and garlic and drying the hot water extract of the seaweed and garlic.
- the seaweed and garlic may be performed by mixing the seaweed and garlic.
- the grasswort may be a ground and dried leaf and stem of the grasswort and dried.
- the garlic may be a fruit of garlic or a pulverized product of the fruit.
- the mixing ratio of the seaweed and garlic is 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) or 9.5: based on the weight ratio in consideration of the anti-hypertension, that is, the function of inhibiting blood pressure and the preference including texture and flavor. It may be mixed in a ratio of 0.5 (seaweed: garlic) to 8: 2 (seaweed: garlic) or 9: 1 (seaweed: garlic).
- the hydrothermal extraction of the mixture of seaweed and garlic may be performed by adding water to the grasswort garlic mixture and adding 70 to 200 ° C or 100 to 175 ° C or 120 to 150 ° C and 5 atm to 20 atm or 10 atm ( atm) to 17 atm or 15 atm for 1 hour to 24 hours or 2 hours to 12 hours or 4 hours to 7 hours.
- the extracting of hot water may further include obtaining a extract by filtering the crude extract obtained after extraction by the above method or obtaining a concentrate by concentrating the extract under reduced pressure.
- Drying the seaweed and garlic hot water extract may be performed by drying the seaweed and garlic hot water extract.
- the drying method may be a method of removing moisture of the seaweed and garlic hot water extract, for example, may be a method of preparing in powder form through a spray drying method.
- composition prepared by using the seaweed and garlic of the present invention unlike ordinary salts, has a NaCl content equivalent to that of sun salt, which is known to have antihypertensive activity, but also has an excellent blood pressure suppression effect, and commonly used edible seaweed and garlic Since the side effects are not a problem because it is used, the effect will be very large industrially.
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a composition for preventing raised blood pressure comprising Salicornia herbacea and garlic. More specifically, sodium chloride and minerals and organic substances contained in Salicornia herbacea and garlic have been prepared by subjecting same to high-pressure hot-water extraction and then spray drying, and the resulting Salicornia herbacea garlic salt has an outstanding effect in reducing oxidative stress without increasing blood pressure, in that it has been confirmed to inhibit enzymes involved in blood pressure elevation, and, when used in salt-sensitive rats, salt intake inevitably raises the blood pressure but, after no more than an initial slight rise, the systolic and diastolic blood pressures hardly increase at all, and, as compared with salt, reduced ACE activity is exhibited, the amount of NO produced is increased, the amount of expression of vascular epidermal growth factor (VEGF) which is involved in lowering blood pressure is heightened, while myosin phosphatase is inhibited and the vascular tone is improved and there is a decreased amount of expression of RhoA, which is involved in raising blood pressure, and oxidative stress in the body is reduced.
Description
본 발명은 혈압 상승 예방 효과를 가지는 조성물 및 그 제조방법에 관한 것이다.The present invention relates to a composition having a blood pressure increase preventing effect and a method for producing the same.
최근 생활수준의 향상과 더불어 평균수명이 연장되면서 만성질환으로 인한 사망률이 증가하고 있으며 WHO는 전 세계 사망원인의 60%를 심혈관계, 당뇨병, 비만, 암 등의 질환이라고 보고하였다. 그 중 심혈관계 질환은 우리나라에서 주요 사망요인으로 지적되고 있으며 심혈관계 질환의 대표적인 질환이 고혈압이다.In recent years, life expectancy has increased, and life expectancy is increasing due to chronic life expectancy. WHO reports that 60% of the causes of death worldwide are diseases such as cardiovascular system, diabetes, obesity and cancer. Among them, cardiovascular disease has been pointed out as the leading cause of death in Korea, and the representative disease of cardiovascular disease is hypertension.
고혈압은 비정상적으로 혈압이 상승되어 있는 상태를 말하며 심혈관의 병을 악화시켜 사망률을 높이는 주된 원인 중 하나로 수축기 혈압이 140 mmHg 이상, 이완기 혈압이 90 mmHg 이상일 경우 고혈압으로 정의하고 있다.Hypertension refers to abnormally elevated blood pressure and is one of the main causes of aggravating cardiovascular disease and increasing mortality. If hypertension is defined as hypertension when the systolic blood pressure is 140 mmHg or more and the diastolic blood pressure is 90 mmHg or more.
고혈압의 종류에는 본태성 고혈압과 이차성 고혈압이 있으며 그 중 본태성 고혈압은 원인을 알 수 없는 고혈압으로 고혈압 환자의 80% 내지 90%를 차지하고 있다.Types of hypertension include essential hypertension and secondary hypertension. Among them, essential hypertension is unknown hypertension and accounts for 80% to 90% of hypertensive patients.
본태성 고혈압의 원인은 확실히 밝혀져 있지 않으나 염 민감성 등의 유전적 요인이 크게 작용하며 또한, 스트레스, 비만, 정신적 상태의 변화, 식염의 과다섭취 등의 원인으로도 발생하는 것으로 알려져 있다.Although the cause of essential hypertension is not clear, genetic factors such as salt sensitivity are greatly affected, and it is also known to be caused by stress, obesity, mental state change, and excessive salt intake.
특히, 염민감성은 본태성 고혈압 환자의 30% 내지 50%를 차지하며 일주일간 고염(200 내지 250 mEq Na+/day)을 섭취하였을 경우 혈압의 10%가 증가한다고 알려져 있다. 현재 WHO/ISH에서는 성인의 소금 일일 섭취량을 5 g이하로, 일본 고혈압 학회(Japanese Society of Hypertension)에서는 7 g이하로 섭취할 것을 권장하고 있다.In particular, the sensitivity is accounted for 30% to 50% of patients with essential hypertension, and 10% of blood pressure is known to increase with high salt (200 to 250 mEq Na + / day) for one week. Currently, the WHO / ISH recommends that adults consume less than 5 g of salt daily, while the Japanese Society of Hypertension recommends less than 7 g.
혈압 상승에 원인되는 주요 성분인 소금은 혈관의 구조의 변화를 유발하고 산화적 스트레스를 유발하여 내피세포의 기능장애 및 심근혈관의 기능저하를 유발시켜 혈압을 상승시키는 등 건강에 부정적인 영향을 미치는 것으로 알려져 있다. 이러한 염분섭취에 따른 문제점들로 인하여 과량의 소금섭취를 지양하고 있다.Salt, which is the main ingredient that causes blood pressure rise, has a negative effect on health, causing changes in blood vessel structure and oxidative stress, causing endothelial dysfunction and cardiovascular dysfunction, which increases blood pressure. Known. Due to the problems associated with salt intake is to avoid excessive salt intake.
동물실험에서의 혈압 연구에 사용한 소금으로는 미네랄이 거의 없는 소금이었으며, 미네랄이 다량 함유된 소금에 대한 연구는 거의 이루어지지 않고 있는 실정이었다. 미네랄 중 Na외 K, Ca, Mg 등의 미네랄은 혈압 상승을 억제하는 것으로 알려져 있다. 즉 K는 NO의 생성을 증가시켜 내피혈관을 이완시키며 Ca은 근육 및 혈관의 수축이완에 영향을 주며 고혈압환자의 경우 혈관을 이완시킴으로 혈압을 감소시킨다. 또한, Mg은 NO 생성 및 혈관구조 등에 변화를 일으켜 혈압에 영향을 주는 것으로 알려져 있다.Salts used in blood pressure studies in animal experiments were salts with few minerals, and very little research was conducted on salts containing a large amount of minerals. Among the minerals, minerals such as Na, K, Ca, and Mg are known to suppress blood pressure rise. In other words, K increases the production of NO to relax the endothelial blood vessels, Ca affects the contraction and relaxation of muscles and blood vessels, and in hypertensive patients, blood pressure is reduced by relaxing the blood vessels. In addition, Mg is known to affect the blood pressure by causing changes in NO production and vascular structure.
소금은 암염, 정제염, 재제염, 천일염 등으로 크게 분류할 수 있으며 소금의 종류에 따라 미네랄 함량이 다른 것으로 알려져 있다. 즉, 전 세계 모든 사람이 주로 먹고 있는 암염과 정제염은 NaCl 함량이 99%이상인 반면 K, Ca, Mg과 같은 미네랄 성분이 거의 없으나 우리나라에서 생산된 갯벌천일염은 NaCl 함량이 85%정도인 반면 K, Ca, Mg과 같은 미네랄 성분의 함량이 매우 높게 나타났다.Salts can be broadly classified into rock salt, refined salt, recontaminated salt and sun salt, and are known to have different mineral contents depending on the type of salt. In other words, rock salts and refined salts consumed by people all over the world have NaCl content of more than 99%, while minerals such as K, Ca, and Mg have almost no minerals, but tidal flat salt produced in Korea has 85% NaCl content, whereas K, The content of minerals such as Ca and Mg was very high.
최근 인슐린 신호 전달에 있어 미네랄이 거의 없는 소금만을 섭취시킨 정상쥐의 경우 인슐린 리셉터 기질-1(insulin receptor substrate-1, IRS-1)의 세린 인산화를 증가시켜 인슐린 신호전달을 저해하였으나 미네랄이 풍부한 천일염을 섭취시킨 쥐는 IRS-1의 세린인산화를 감소시켜 인슐린신호 전달을 증가시키고 포도당 이용률을 증가시키는 사실을 밝혔다.Recently, rats that consumed only a few minerals in insulin signaling inhibited insulin signaling by increasing serine phosphorylation of insulin receptor substrate-1 (IRS-1), but mineral-rich sun salt Rats have been shown to reduce serine phosphorylation of IRS-1 to increase insulin signal transduction and increase glucose utilization.
또한, 미네랄이 풍부한 소금이 염민감쥐와 정상쥐에서 미네랄이 거의 없는 소금에 비해 혈압의 상승을 억제하고 산화적 손상도 줄여 준다고 밝혀지고 있다. 따라서 Na를 제외한 K, Ca, Mg 등의 미네랄 성분들은 혈압 상승 억제 혹은 인슐린 저항성을 낮추는데 긍정적인 영향을 주는 것으로 시사되었다.In addition, salts rich in minerals have been shown to reduce blood pressure and reduce oxidative damage in salt and rats compared to salts with little or no minerals. Therefore, minerals such as K, Ca, and Mg except Na have a positive effect on suppressing blood pressure rise or lowering insulin resistance.
한편, NaCl 농도를 낮추고 다른 미네랄 성분을 인위적으로 첨가한 저염소금 제품도 출시되고 있다. 그러나 미네랄에 따라 다소 차이가 있지만 인체에 이롭고 해로운 미네랄의 농도 범위는 매우 좁으므로 균형 잡힌 미네랄이 함유된 소금의 섭취가 건강에 더 이로울 것으로 판단된다. 그러나 적정농도의 미네랄이 함유된 좋은 소금(갯벌천일염)이라 할지라도 소금단독으로는 혈압 상승을 줄이는 데는 한계가 있다.Meanwhile, low-chlorine products with low NaCl concentration and artificially added other minerals are also on the market. However, the concentration of minerals that are beneficial and harmful to the human body is very narrow, although there are some differences depending on the minerals. Therefore, intake of salt containing balanced minerals may be more beneficial to health. However, even salt that contains an appropriate concentration of minerals (tidal flat salt), salt alone has a limit in reducing blood pressure rise.
천연자원으로부터 얻어진 유기물질과 미네랄이 풍부한 소금을 동시에 섭취하였을 때 혈압 상승 억제 효과가 있을 것으로 기대된다. 체중 증가 등의 부작용이 없고, 장기간 사용하여도 내성이나 안정성에 대한 문제가 대두되어지지 아니한 천연물질 유래의 혈압 상승 예방용 조성물을 개발하는 것이 시급한 실정이다. 특히, 3면이 바다이어서, 해양자원이 풍부한 우리나라의 지리적 환경을 고려하여, 해양 천연물질로부터 혈압 상승을 예방할 수 있는 조성물을 개발하고자 하는 요구가 증가되고 있다.Intake of salts rich in organic substances and minerals from natural sources is expected to have an effect on suppressing blood pressure rise. There is an urgent need to develop a composition for preventing blood pressure rise derived from natural substances that does not have side effects such as weight gain and does not raise resistance or stability even after long-term use. In particular, the three sides are the sea, in consideration of the geographical environment of Korea, which is rich in marine resources, there is an increasing demand to develop a composition that can prevent blood pressure rise from natural marine materials.
본 발명은 상기와 같은 종래기술의 문제점을 개선하기 위한 것으로, 혈압상승 예방 또는 개선용 조성물, 구체적으로 짠 맛을 낼 수 있어서, 소금을 대체할 수 있으면서도, 소금과 달리 혈압 상승을 예방 또는 개선할 수 있는 소금 대체용 조성물 및 그 제조방법을 제공하는 것을 목적으로 한다.The present invention is to improve the problems of the prior art as described above, to prevent or improve the composition of blood pressure increase, specifically to taste salty, while being able to replace salt, unlike salt to prevent or improve blood pressure rise It is an object of the present invention to provide a salt replacement composition and a method for producing the same.
상기 목적을 달성하기 위하여, 본 발명은 함초와 마늘로부터 제조된 소금 대체용 식품 첨가물 조성물을 제공하는 것을 목적으로 한다. 상기 식품 첨가물 조성물은 혈압 상승 예방, 억제 또는 개선용 효과를 가지는 것일 수 있다.In order to achieve the above object, it is an object of the present invention to provide a food substitute composition for salt replacement prepared from seaweed and garlic. The food additive composition may have an effect of preventing, suppressing or improving blood pressure.
구체적으로, 상기 소금 대체용 식품 첨가물 조성물은 함초 및 마늘 혼합물의 열수 추출물을 유효성분으로 포함하는 고혈압 억제 또는 예방 효과가 있는 소금 대체용 식품 첨가물 조성물일 수 있다.Specifically, the salt substitute food additive composition may be a salt substitute food additive composition having a high blood pressure suppressing or preventing effect including hot water extracts of the mixture of seaweed and garlic as an active ingredient.
보다 구체적으로, 상기 소금 대체용 식품 첨가물 조성물은 함초의 잎 및 줄기를 건조하고 마쇄한 함초 마쇄물 및 마늘을 중량을 기준으로 9.9:0.1(함초:마늘) 내지 7:3(함초:마늘)의 함량비로 혼합하는 단계; 상기 함초 및 마늘 혼합물을 100 내지 175℃ 및 10 기압(atm) 내지 17 기압(atm)의 조건에서 2시간 내지 12시간 동안 열수 추출하여 함초 및 마늘 열수 추출물을 제조하는 단계 및 상기 함초 및 마늘 열수 추출물을 분무건조하여 건조하는 단계를 포함하는 방법으로 제조한 것인 고혈압 억제 또는 예방 효과가 있는 소금 대체용 식품 첨가물 조성물일 수 있다.More specifically, the salt substitute food additive composition is dried crushed leaf and stem of the seaweed and ground crushed seaweed ground and garlic based on the weight of 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) Mixing at a content ratio; Hot water extraction for 2 hours to 12 hours at 100 to 175 ℃ and 10 atm (atm) to 17 atm (atm) of the mixture of the seaweed and garlic mixture to prepare a hot water extract and garlic and hot water extract It may be a salt substitute food additive composition having a high blood pressure inhibiting or preventing effect that is prepared by the method comprising the step of spray drying to dry.
또한, 본 발명은 함초의 잎 및 줄기를 건조하고 마쇄한 함초 마쇄물 및 마늘을 중량을 기준으로 9:1(함초:마늘)로 혼합하는 단계; 상기 함초 및 마늘 혼합물을 130℃ 및 15기압(atm)의 조건에서 5시간 동안 열수 추출하여 함초 및 마늘 열수 추출물을 제조하는 단계 및 상기 함초 및 마늘 열수 추출물을 분무건조하여 건조하는 단계를 포함하는 혈압상승 억제 또는 예방 효과가 있는 함초마늘소금의 제조방법일 수 있다.In addition, the present invention comprises the step of mixing the leaves and stems of the vinegar and dried and ground crushed seaweed grinding and garlic by 9: 1 (seaweed: garlic) by weight; Blood pressure comprising the step of producing hot water extract and the hot water extract garlic and garlic hot water extract for 5 hours under conditions of 130 ℃ and 15 atm (atm) and spray drying the water and garlic hot water extract It may be a method of preparing a seaweed garlic salt having a synergistic inhibitory or preventive effect.
본 발명의 함초와 마늘을 이용하여 제조된 조성물, 즉 함초와 마늘을 이용하여 제조된 소금은 일반 소금 보다 우수한 항고혈압 활성을 갖는 것으로 알려진 천일염과 동등한 NaCl 함량을 가지면서도 우수한 혈압상승억제 효과를 갖는 것으로 확인되었다. 구체적으로, 본 발명의 제조방법에 의해 제조된 함초마늘소금은 혈압상승인자인 안지오텐신 전환 효소 저해 활성을 갖고, 염민감쥐를 이용하여 확인한 결과, 소금 섭취로부터 오는 혈압 상승을 거의 완벽하게 억제할 뿐만 아니라 산화적 스트레스를 줄여 주므로, 소금 섭취에 의한 혈압상승을 억제할 수 있는 것으로 확인되었다.The composition prepared by using the seaweed and garlic of the present invention, that is, the salt prepared by using the seaweed and garlic, has an excellent antihypertensive effect while having NaCl content equivalent to that of a natural salt known to have superior antihypertensive activity than ordinary salts. It was confirmed that. Specifically, the seaweed garlic salt prepared by the preparation method of the present invention has angiotensin converting enzyme inhibitory activity, which is a blood pressure increase factor, and confirmed by using salty rats, as a result, almost completely suppresses the blood pressure increase resulting from salt intake. Rather, because it reduces oxidative stress, it was confirmed that the blood pressure increase caused by salt intake could be suppressed.
을 뿐만 아니라, 일반적으로 식용하는 함초와 마늘을 이용하는 것이어서 부작용 등이 문제되지 아니하고, 우리나라 서해안 특히, 전라남도에서 풍부하게 생산되는 함초와 마늘을 이용하는 것이므로 경제적으로도 유리하여 산업적으로 그 효과가 매우 크다 할 것이다.In addition, the use of edible seaweed and garlic in general is not a side effect, and the problem is not a problem, and because it is economically advantageous because it uses the seaweed and garlic produced abundantly in the west coast of Korea, especially Jeollanam-do, the effect is very large industrially. will be.
도 1은 본 발명의 일 실시예에 따른 혈압 상승 억제 효과가 있는 기능성 소금인 함초마늘소금을 제조하는 방법을 개략적으로 나타낸 순서도이다.1 is a flow chart schematically showing a method of manufacturing a seaweed garlic salt, which is a functional salt having a blood pressure increase suppressing effect according to an embodiment of the present invention.
도 2는 본 발명의 일 실시예에 따른 함초마늘소금을 염민감쥐에 사용할 경우 함초마늘소금을 식이하는 동안 소금 섭취로부터 오는 수축기 혈압 상승을 억제하는 효과를 천일염 식이군 및 함초소금 식이군과 비교하여 나타낸 그래프이다.Figure 2 compares the effect of inhibiting the increase in systolic blood pressure from salt intake during dietary preparation of seaweed garlic salt when saltwort garlic salt is used in salt-infested rats according to an embodiment of the present invention. It is a graph shown.
도 3은 본 발명의 일 실시예에 따른 함초마늘소금을 염민감쥐에 사용할 경우 함초마늘소금을 식이하는 동안 소금 섭취로부터 오는 이완기 혈압 상승을 억제하는 효과를 천일염 식이군 및 함초소금 식이군과 비교하여 나타낸 그래프이다.Figure 3 compares the effect of inhibiting the increase in diastolic blood pressure from salt intake during dietary preparation of seaweed garlic salt in comparison with the salt salt group and sea salt diet group It is a graph shown.
도 4는 본 발명의 일 실시예에 따른 함초마늘소금을 염민감쥐에 사용할 경우 함초마늘소금 식이군 혈장에서의 혈압 상승 효소인 안지오텐신 전환 효소 활성을 나타낸 그래프이다.Figure 4 is a graph showing the angiotensin converting enzyme activity of the blood pressure-enhancing enzymes in the plasma of the saltwort garlic salt group when the saltwort garlic salt according to an embodiment of the present invention in salty rats.
도 5는 본 발명의 일 실시예에 따른 함초마늘소금을 염민감쥐에 사용할 경우 함초마늘소금 식이가 신장에서 NO 생성량을 증가시켜 혈압을 낮추는데 관여하는 혈관내피성장인자(VEGF)의 발현량을 높이는 효과가 있음을 나타낸 사진이다.Figure 5 is to increase the expression level of vascular endothelial growth factor (VEGF) involved in lowering blood pressure by increasing the amount of NO production in the kidney when the seaweed garlic salt according to an embodiment of the present invention in salty rats It shows the effect.
도 6은 본 발명의 일 실시예에 따른 함초마늘소금을 염민감쥐에 사용할 경우 함초마늘소금 식이가 신장에서 미오신 인산화 효소를 저해하여 혈관긴장도(vascular tone)를 높여 혈압을 상승시키는데 관여하는 RhoA 발현량을 낮추는 효과가 있음 나타낸 그래프이다.6 is a RhoA expression involved in increasing the blood pressure by increasing the vascular tone by inhibiting myosin phosphatase in the kidney when the seaweed garlic salt is used in salty mice according to an embodiment of the present invention. It is a graph showing the effect of lowering the amount.
도 7은 본 발명의 일 실시예에 따른 함초마늘소금을 염민감쥐에 사용할 경우 함초마늘소금 식이가 혈장에서 지질 과산화물 생성을 줄여 주고 있음을 나타낸 결과로부터 항산화활성을 나타낸 그래프이다.7 is a graph showing the antioxidant activity from the results showing that the seaweed garlic salt diet reduces lipid peroxides in the plasma when the seaweed garlic salt according to an embodiment of the present invention is used in salty rats.
이하, 본 발명의 바람직한 실시예를 기재한다. 다만, 하기의 실시예는 본 발명의 바람직한 일 실시예일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, preferred embodiments of the present invention are described. However, the following examples are only preferred embodiments of the present invention, and the present invention is not limited to the following examples.
실시예 1. 함초와 마늘을 포함하는 기능성 가공소금의 제조Example 1. Preparation of functional processed salt containing seaweed and garlic
본 발명에 사용한 함초는 전라남도 증도에서 자생한 것으로, 2008년에 이를 채취한 후 자연 건조시킨 것을 사용하였다. 본 발명에 사용한 마늘은 2008년에 전라남도 신안군에서 재배된 것을 구입하여 사용하였다.The seaweed used in the present invention was grown in Jeollanam-do, Jeollanam-do, and it was used after it was naturally dried after harvesting it in 2008. Garlic used in the present invention was used in 2008 purchased in Shinan-gun, Jeollanam-do.
함초와 마늘을 이용한 함초마늘소금의 제조 방법은 도 1에 제시한 바와와 같다. 보다 구체적으로, 상기 자연 채취 후 건조시킨 건함초 1,000 g, 상기 건함초 900 g 및 생마늘 100 g 또는 상기 건함초 700 g 및 생마늘 300 g을 각각 혼합한 다음 여기에 물 10 L를 가하여 고압추출장치에 넣었다. 상기 건함초와 생마늘 혼합물을 130℃의 온도 조건 및 15 기압(atm)의 압력 조건에서 5시간을 고압 열수로 추출한 다음 여과하여 함초마늘고압열수추출액을 수득하였다. 상기 수득된 함초마늘고압열수추출액을 분무건조기를 이용하여 분무건조하여 함초식물소금(GG)을 제조하였다.A method of preparing seaweed garlic salt using seaweed and garlic is as shown in FIG. 1. More specifically, 1,000 g of dried dried seaweed, 900 g of dried seaweed and 100 g of dried garlic or 700 g of dried seaweed, and 300 g of dried garlic, respectively, were mixed, and then 10 L of water was added thereto to the high-pressure extractor. Put in. The dried seaweed and fresh garlic mixture were extracted with high-pressure hot water for 5 hours at a temperature of 130 ° C. and a pressure of 15 atmospheres (atm), followed by filtration to obtain a high-pressure hot water extract. The obtained seaweed garlic high pressure hot water extract was spray-dried using a spray dryer to prepare seaweed plant salt (GG).
실시예 2. 함초식물소금들의 이화학적 특성Example 2 Physicochemical Properties of Seaweed Plant Salts
상기 실시예 1에서 제조된 함초마늘소금의 이화학적 특성을 조사하였다. 상기 이화학적 특성을 측정한 결과는 하기 표 1에 나타내었다. The physicochemical characteristics of seaweed garlic salt prepared in Example 1 were investigated. The results obtained by measuring the physicochemical properties are shown in Table 1 below.
보다 구체적으로, 상기 함초마늘소금의 pH는 시료 농도를 10% 용액으로 한 다음 pH 메터를 이용하여 측정하였고, 염도는 모르(Mohr)법에 의해 측정하였다.More specifically, the pH of the seaweed garlic salt was measured by using a pH meter after the sample concentration was a 10% solution, and salinity was measured by the Mohr method.
표 1
Table 1
시료 | pH | 염화나트륨(%) |
함초소금 | 6.54 | 55.5 |
함초마늘소금1(9:1(함초중량:마늘)) | 4.34 | 38.0 |
함초마늘소금2(7:3(함초중량:마늘)) | 4.48 | 35.5 |
sample | pH | Sodium Chloride (%) |
Seaweed Salt | 6.54 | 55.5 |
Seaweed Garlic Salt 1 (9: 1 (Seaweed Weight: Garlic)) | 4.34 | 38.0 |
Seaweed Garlic Salt 2 (7: 3 (Seaweed Weight: Garlic)) | 4.48 | 35.5 |
상기 표 1에 나타낸 바와 같이, 함초고압열수추출물로부터 제조된 함초소금의 pH가 pH 6.54이었고, 마늘과 함께 고압열수로 추출한 함초마늘고압열수추출물로부터 제조된 함초마늘소금의 pH는 pH 4.34 또는 pH 4.48이었다. 함초만을 고압 열수추출하여 얻어진 함초소금 즉, 함초고압열수추출물로부터 제조된 함초소금은 염도가 55.5%이었으며 마늘 첨가량이 많아질수록 염도는 감소하는 경향을 나타냈다.As shown in Table 1, the pH of the saltwort salt prepared from the high-pressure hot water extract of seaweed was pH 6.54, and the pH of the seaweed garlic salt prepared from the high-pressure hot water extract extracted with high-pressure hot water with garlic was pH 4.34 or pH 4.48. It was. The saltwort salt obtained from the high-pressure hot water extract of only the seaweed, that is, the seaweed salt prepared from the high-pressure hot water extract of seaweed, had a salinity of 55.5% and the salinity tended to decrease as the amount of garlic added increased.
실시예 3. 함초마늘소금들의 안지오텐신 전환 효소 (ACE) 저해 활성Example 3. Angiotensin Converting Enzyme (ACE) Inhibitory Activity of Seaweed Garlic Salts
상기 실시예 1에서 제조된 함초마늘소금의 항고혈압 활성을 확인하기 위하여, 우선적으로 안지오텐신 전환 효소 저해활성을 확인하였으며, 그 결과를 표 2에 나타내었다.In order to confirm the antihypertensive activity of the seaweed garlic salt prepared in Example 1, the angiotensin converting enzyme inhibitory activity was first confirmed, and the results are shown in Table 2.
보다 구체적으로, 0.3 M NaCl을 함유한 0.1 M sodium borate buffer(pH 8.3)에 rabbit lung acetone powder(Sigma, USA)를 1g/10ml(w/v)의 농도로 4℃에서 24시간 동안 추출한 후, 40분간 4℃, 4000×g로 원심분리하여 안지오텐신 전환 효소 조효소액을 얻었다.More specifically, after rabbit rabbit acetone powder (Sigma, USA) in 0.1 M sodium borate buffer (pH 8.3) containing 0.3 M NaCl at a concentration of 1g / 10ml (w / v) for 24 hours at 4 ℃, The angiotensin converting enzyme coenzyme liquid was obtained by centrifuging at 4000 degreeC and 4 degreeC for 40 minutes.
상기 안지오텐신 전환 효소 저해활성은 상기 각각의 소금을 이용하여 제조된 1% 농도의 시료 50 μl에 0.1 M sodium borate buffer(pH 8.3) 100 μl와 상기 수득한 안지오텐신 전환 효소 조효소액 50 μl를 가한 다음 37℃에서 5분간 예비반응시킨 후, 0.3 M NaCl이 함유된 0.1 M sodium borate buffer(pH 8.3) 5 ml에 HHL(hippuryl histidyl leucine) 25 mg을 첨가하여 만든 기질 50 μl를 첨가하여 37℃에서 30분간 반응시켰다.The angiotensin converting enzyme inhibitory activity was added to 100 μl of 0.1 M sodium borate buffer (pH 8.3) and 50 μl of the obtained angiotensin converting enzyme coenzyme solution to 50 μl of the 1% sample prepared using each salt. After preliminary reaction for 5 minutes at 50 ° C., 50 μl of substrate prepared by adding 25 mg of hippuryl histidyl leucine (HHL) to 5 ml of 0.1 M sodium borate buffer (pH 8.3) containing 0.3 M NaCl was added for 30 minutes at 37 ° C. Reacted.
상기 반응 후 1 N HCl 250 μl를 가하여 반응을 정지시키고, ethyl acetate 1.5 ml을 가해 15초간 교반한 후 5분간 4℃ 및 3000×g의 조건으로 원심분리하여 상등액 1 ml을 얻었다. 상기 상등액을 120℃에서 30분간 완전히 건조시킨 후, 다시 증류수 3 ml을 넣고, 228 nm에서 흡광도를 측정하여 안지오텐신 전환 효소 저해활성을 측정하였으며, 그 결과를 하기 표 2에 나타내었다.After the reaction, 250 μl of 1 N HCl was added to stop the reaction, 1.5 ml of ethyl acetate was added thereto, stirred for 15 seconds, and centrifuged at 4 ° C. and 3000 × g for 5 minutes to obtain 1 ml of a supernatant. After completely drying the supernatant at 120 ° C. for 30 minutes, 3 ml of distilled water was added again, and the absorbance at 228 nm was measured to measure angiotensin converting enzyme inhibitory activity, and the results are shown in Table 2 below.
대조구로서는 상기 소금 대신 증류수 50 μl를 넣어 실험하였으며, 안지오텐신 전환 효소 저해활성효과는 다음 계산식을 이용하여 계산하였다.As a control, 50 μl of distilled water was put in place of the salt, and the angiotensin converting enzyme inhibitory activity was calculated using the following formula.
[계산식][formula]
표 2
TABLE 2
시료 | 엔지오테신 전환 효소 (ACE) 저해 활성 (%) |
함초소금 | 40.51 |
함초마늘소금1(9:1(함초중량:마늘)) | 60.00 |
함초마늘소금2(7:3(함초중량:마늘)) | 67.11 |
sample | Enzyotene converting enzyme (ACE) inhibitory activity (%) |
Seaweed Salt | 40.51 |
Seaweed Garlic Salt 1 (9: 1 (Seaweed Weight: Garlic)) | 60.00 |
Seaweed Garlic Salt 2 (7: 3 (Seaweed Weight: Garlic)) | 67.11 |
상기 표 2에 나타낸 바와 같이, 상기 실시예 1에서 수득한 함초소금과 함초마늘소금 모두 안지오텐신 전환 효소 저해 활성을 나타냈다. 특히, 마늘이 첨가된 함초마늘소금은 함초소금보다 안지오텐신 전환 효소 저해 활성이 높았으며 마늘 첨가량이 많을수록 그 저해활성이 높아지는 경향을 보였다. 그러나, 마늘 첨가량이 많아질수록 염도가 낮아지고 마늘 향이 너무 강하여 좋지 못한 풍미를 줄 것으로 시사되었다. 따라서, 함초마늘소금의 제조 시 함초 900 g에 마늘 100 g을 혼합하는 것이 적합하다고 판단되었다.As shown in Table 2, both the seaweed salt and seaweed garlic salt obtained in Example 1 showed angiotensin converting enzyme inhibitory activity. In particular, garlic-containing garlic salts had higher angiotensin-converting enzyme inhibitory activity than that of salt-containing salts, and the more garlic was added, the higher the inhibitory activity was. However, as the amount of garlic added increased, the salinity was lowered, and the garlic aroma was too strong, suggesting a bad flavor. Therefore, it was judged that it is suitable to mix 100 g of garlic with 900 g of seaweed during the preparation of seaweed garlic salt.
실시예 4. 동물실험에서 함초마늘소금의 혈압 상승 억제 효과Example 4 Inhibitory Effect of Seaweed Garlic Salt on Blood Pressure Rise in Animal Experiments
상기 실시예 3에서 안지오텐신 전환 효소 저해 활성을 통하여 항고혈압 활성을 갖는 것으로 확인된 상기 실시예 1에서 제조된 함초소금과 함초마늘소금을 염민감쥐에 사용할 경우 소금 섭취로부터 오는 혈압상승을 억제하는지 여부를 확인하였다.In Example 3, the anti-hypertensive activity was confirmed by using angiotensin converting enzyme inhibitory activity, and when the saltwort salt and the seaweed garlic salt prepared in Example 1 were used in salty rats, whether the blood pressure increase resulting from salt ingestion was suppressed. It was confirmed.
본 발명에 사용된 실험동물은 8주령의 염민감쥐(Male Dahl salt-sensitive rat)를 다물과학(Damool Science Co., 대한민국)으로부터 구입하여 사용하였으며, 이들의 평균체중은 390 ± 20 g이었다.The experimental animals used in the present invention were purchased from Daolol Science Co., South Korea, 8-week-old male Dahl salt-sensitive rats, their average weight was 390 ± 20 g.
상기 염민감쥐들은 AIN-93G 기준으로 일반사료를 제조하여 사육하였고, 20℃의 온도조건, 상대습도 50% 내지 60%의 습도조건 및 조명주기 12시간의 조명조건으로 사육하였으며, 물과 식이는 자유롭게 섭취하도록 하였다. 상기 실험동물은 2주간 적응시킨 후 체중을 측정하여 각각의 실험집단(n=4)으로 분류하였다.The salted mice were prepared by breeding general feed on the basis of AIN-93G, and were bred under conditions of temperature of 20 ° C., humidity of 50% to 60% relative humidity, and lighting conditions of 12 hours of lighting cycle. Free to eat. The experimental animals were acclimated for 2 weeks and then weighed and classified into each experimental group (n = 4).
상기 실험동물 중 실험군은 각 처리군에 3% 염화나트륨 함량이 되도록 맞추어 사료를 제조하였다. 상기 제조된 사료는 상기 실시예 2에서 확인된 함초소금과 함초마늘소금의 NaCl 함량을 고려하여, 함초소금과 함초마늘소금의 투여량을 조절하였다. 구체적으로, 각각 3% 천일염(w/w, 천일염군), 2% 천일염과 약 2% 함초소금이 첨가된 사료(함초소금식이군) 및 2% 천일염과 약 2% 함초마늘소금이 첨가된 사료(함초마늘소금식이군)로 하는 고염식이 사료를 제조하였다.Of the experimental animals, the experimental group was prepared to meet the 3% sodium chloride content in each treatment group. The prepared feed was adjusted in consideration of the NaCl content of the seaweed salt and seaweed garlic salt identified in Example 2, the dose of the seaweed salt and seaweed garlic salt. Specifically, feeds containing 3% sun salt (w / w, sun salt group), 2% sun salt and about 2% sea salt, and diets containing 2% sun salt and about 2% seaweed garlic salt respectively. A high salt diet was prepared using (Soncho garlic salt group).
상기 실험동물을 이용하여 함초마늘소금의 혈압 상승 상승 억제 효과를 검정을 위해 사용한 혈압 측정은 tail-cuff법을 응용하여 사용하였다.The blood pressure measurement used for assaying the effect of inhibiting the increase in blood pressure of seaweed garlic salt using the experimental animal was used by applying the tail-cuff method.
구체적으로, 상기 혈압을 측정할 때 쥐들은 좁은 cage에 넣어져 안정이 될 때까지 많은 시간이 소요되고 또한 꼬리에 측정기를 설치함으로써 외부로부터 많은 스트레스를 받게 되어 분석된 혈압수치의 편차가 큰 단점을 보완하기 위하여, 실험초기에 실험동물의 대퇴부 동맥 내에 혈압측정 sensor를 삽입한 다음 원격으로 자유롭게 혈압을 측정할 수 있는 PA-C40 Transmitter(Data Sciences International: DSI, USA)측정기를 이용하여 식이하는 동안 수축기와 이완기 혈압을 측정하였다. 상기 혈압측정결과를 도 2 및 도 3에 나타내었다.Specifically, when the blood pressure is measured, the rats are put in a narrow cage and take a long time to stabilize, and also a large amount of stress from the outside is provided by installing a measuring device in the tail, so that the deviation of the analyzed blood pressure value is large. To compensate, the systolic system can be inserted at the beginning of the experiment using a PA-C40 Transmitter (Data Sciences International: DSI, USA), which inserts a blood pressure sensor into the femoral artery of the animal and freely measures blood pressure remotely. And diastolic blood pressure were measured. The blood pressure measurement results are shown in FIGS. 2 and 3.
구체적으로, 수축기혈압은 도 2에 나타내었다. 상기 도 2에 나타낸 바와 같이, 천일염식이군과 함초소금식이군은 식이기간 중 지속적으로 수축기 혈압이 상승하였다. 이는 염민감쥐가 소금을 섭취하였을 때 혈압이 상승하는 결과와 일치하는 것으로 확인되었다. 또한, 함초소금식이군은 천일염식이군보다 낮은 상승 폭을 나타내었다.Specifically, systolic blood pressure is shown in FIG. 2. As shown in FIG. 2, the SUN diet group and the seaweed salt diet group continuously increased systolic blood pressure during the diet period. This is consistent with the results of elevated blood pressure when salted rats ingest salt. In addition, the hamcho salt diet group showed a lower rise than the sun salt diet group.
한편, 함초마늘소금식이군은 식이 6일까지 수축기 혈압이 상승하였으나 이후 식이 기간 동안 그 수치가 상승하지 않고 그대로 유지하는 경향을 보였다. 특히, 함초마늘소금식이군은 함초소금식이군 및 천일염식이군에 비해 낮은 수축기 혈압을 유지하였는데 식이 18일부터 그 수치가 현저하게 차이를 보였으며 식이 4주후에는 유의적인 차이를 나타냈다. 과다 소금 섭취는 고혈압이나 당뇨 등의 대사성 증후군과 관련된 질환에 직접적인 영향을 주는 것으로 보고되어 있다.On the other hand, the seaweed garlic salt group showed a systolic blood pressure increase up to 6 days after the diet, but it did not increase during the diet period. In particular, the hamcho garlic salt group maintained a lower systolic blood pressure than the hamcho salt diet group and sun salt diet group, and showed significantly different values from the 18th day of diet, and showed a significant difference after 4 weeks of diet. Excess salt intake has been reported to have a direct impact on diseases associated with metabolic syndrome, such as hypertension and diabetes.
또한, 정상쥐 및 염민감쥐 등의 다양한 동물실험모델을 통하여 천일염과 같이 미네랄이 풍부한 소금이 정제염과 같이 미네랄이 거의 없는 소금보다 혈압 상승을 완화시켰다고 보고된 바 있다.In addition, it has been reported that salts rich in minerals, such as sun salt, alleviated blood pressure rise, compared to salts containing almost no minerals, such as purified salts, through various animal experiment models such as normal rats and salt-mined mice.
상기 실험에서 확인된 바와 같이 염민감쥐에서 함초마늘소금이 미네랄이 풍부한 소금 즉 천일염과 달리 수축기 혈압 상승이 거의 없었던 것은 기존 보고된 자료에 비하여 함초마늘소금의 항고혈압 활성이 현저하게 우수한 것을 의미하는 것으로 해석될 수 있다.As confirmed in the above experiments, the salinary garlic salt had little increase in systolic blood pressure unlike the salt rich salt, that is, the salt of sea salt, in salted rats, which means that the antihypertensive activity of seaweed garlic salt was remarkably superior to previously reported data. It can be interpreted as.
또한, 이완기혈압은 도 3에 나타내었다. 상기 도 3에 나타낸 바와 같이, 각 식이군의 이완기 혈압은 식이하는 동안 수축기 혈압 결과와 유사한 경향을 나타내었다. 구체적으로, 천일염식이군과 함초소금식이군은 식이기간 중 지속적으로 이완기 혈압이 상승하였고, 함초소금식이군은 천일염식이군보다 낮은 상승 폭을 나타내었으나, 집단 간의 유의적 차이는 없는 것으로 확인되었다.In addition, diastolic blood pressure is shown in FIG. As shown in Figure 3, the diastolic blood pressure of each diet group showed a similar tendency to systolic blood pressure results during the diet. Specifically, the SPA and Hamcho salt diets showed a steady increase in diastolic blood pressure during the diet, and the Shamcho salt diet group showed a lower rise than the SUN diet group, but there was no significant difference between the groups.
한편, 함초마늘소금식이군은 식이 6일까지 이완기 혈압이 상승하였으나 이후 식이 기간 동안 그대로 유지하는 경향을 보여 수축기 혈압 결과와 일치함을 알 수 있었다. 즉, 수축기 혈압 결과와 마찬가지로 함초마늘소금은 이완기 혈압을 상승시키지 않는 것으로 해석되었다.On the other hand, the hamcho garlic salt group showed that the diastolic blood pressure increased until the 6th day of diet, but the systolic blood pressure was shown to be consistent with the systolic blood pressure result. In other words, as with systolic blood pressure results, seaweed garlic salt did not increase diastolic blood pressure.
따라서, 함초마늘소금은 기존 소금 즉, 천일염 또는 함초소금과 달리 혈압 상승 억제 효과가 우수한 것으로 판단되었다.Therefore, the seaweed garlic salt was judged to have an excellent effect of suppressing blood pressure increase, unlike conventional salts, such as sun salt or seaweed salt.
실시예 5. 함초마늘소금의 혈압 상승 인자인 안지오텐신 전환 효소 활성 억제 효과 확인Example 5 Confirming the Inhibitory Effect of Angiotensin Converting Enzyme Activity of Blood Pressure Garlic Salt
상기 실시예 4에서 동물실험에서 얻어진 혈액를 채취하여 함초마늘소금식이군의 안지오텐신 전환 효소 활성을 측정하였다. Blood obtained in the animal experiment in Example 4 was collected and the angiotensin converting enzyme activity of the seaweed garlic salt diet group was measured.
구체적으로, 실험동물은 희생 전 12시간 절식시킨 다음 에테르로 마취한 후 경추분리에 의해 희생하였다. 동물의 복부에서부터 흉부까지 개복하고 심장박동이 유지되고 있는 상태로 심장에서 직접 채혈하였다. 이후 간조직, 지방조직, 근육조직을 분리한 다음 이를 얼음으로 냉각시킨 생리식염수로 세척한 후 -70℃에서 분석에 사용될 때까지 보관하였다.Specifically, the experimental animals were sacrificed by cervical separation after fasting 12 hours before sacrifice and anesthesia with ether. The animals were opened from the abdomen to the thorax and blood was collected directly from the heart with the heart rate maintained. The liver, adipose and muscle tissues were then separated and washed with physiological saline cooled by ice and stored at -70 ° C until use for analysis.
모든 식이군의 안지오텐신 전환 효소 활성은 얻어진 혈청 (50 μL)에 기질 300 mM NaCl을 함유하고 있는 100 mM sodium borate buffer 용액(pH 8.3)에 용해시킨 5 mM 기질(Hip-His-Leu, 150 μL)을 가하여 혼합한 다음 37 ℃에서 45 분 동안 반응시켰다. 상기 반응용액에 2N HCl 200 μL를 가하여 효소반응을 정지시킨 다음, 여기에 2.0 mL의 에틸아세테이트를 분배하였다. 상기 수득한 에틸아세테이트를 10분 동안 1000×g로 원심분리한 후 상층액 1.5 mL를 글라스 튜브(glass tube)로 옮겨 상온에서 감압농축하였다. 상기 농축된 수득물에 1 mL의 증류수를 가하여 용해시킨 다음 228 nm에서 흡광도를 측정하였다.Angiotensin converting enzyme activity of all diets was obtained by dissolving 5 mM substrate (Hip-His-Leu, 150 μL) dissolved in 100 mM sodium borate buffer solution (pH 8.3) containing 300 mM NaCl substrate in serum (50 μL). The mixture was added and mixed, followed by reaction at 37 ° C. for 45 minutes. 200 μL of 2N HCl was added to the reaction solution to stop the enzyme reaction, and then 2.0 mL of ethyl acetate was distributed thereto. The obtained ethyl acetate was centrifuged at 1000 x g for 10 minutes, and then 1.5 mL of the supernatant was transferred to a glass tube and concentrated under reduced pressure at room temperature. 1 mL of distilled water was added to the concentrated product, dissolved, and the absorbance was measured at 228 nm.
상기 각 식이군의 안지오텐신 전환 효소 활성은 표준용액(hippuric acid)의 검량곡선을 이용하여 상기 흡광도값을 히프릭산(hippuric acid) 생성량으로 환산하는 방법으로 확인하였다. 상기 확인 결과를 도 4에 나타내었다.The angiotensin converting enzyme activity of each diet group was confirmed by converting the absorbance value into the amount produced by the hypric acid using a calibration curve of the standard solution (hippuric acid). The confirmed result is shown in FIG. 4.
상기 도 4에 제시한 바와 같이, 함초소금식이군 혈장에서의 안지오텐신 전환 효소 활성은 천일염식이군 간의 유의적인 차이를 보이지 않았으나 약간 낮은 저해 활성을 나타내 수축기와 이완기 혈압 결과와 같은 경향을 나타내었다. 한편, 함초마늘소금식이군은 함초소금식이군과 천일염식이군보다 유의적으로 낮은 안지오텐신 전환 효소 활성을 나타내었다.As shown in FIG. 4, the angiotensin converting enzyme activity in the plasma of the saltwort group was not significantly different between the salt group, but showed a slightly lower inhibitory activity, showing the same tendency as the systolic and diastolic blood pressure results. On the other hand, hamcho garlic salt group showed significantly lower angiotensin converting enzyme activity than hamcho salt diet group and sun salt diet group.
레닌-엔지오텐신-알도스테론 체계(renin-angiotensin-aldosterone system)은 우리 몸에서 혈압과 물의 평행을 조절하는 중요한 인자이다. 즉 ,우리 몸에 수분이 부족하게 되면 신장에서 레닌이 분비되고 이어 간에서 생산한 안지오텐신(angiotensin)이 혈관을 수축시키고, 이 때 알도스테론 호르몬에 의해 신장으로부터 물과 나트륨을 혈액에 보내어 혈압을 상승시킨다고 알려져 있다. 특히, 안지오텐신 전환 효소의 발현량이 적다는 것은 체내 혈압이 낮다는 의미로 해석할 수 있다.The renin-angiotensin-aldosterone system is an important factor in controlling the parallel between blood pressure and water in our bodies. In other words, when the body lacks water, renin is released from the kidneys, and then angiotensin produced by the liver constricts blood vessels. At this time, aldosterone hormone sends water and sodium from the kidneys to the blood to raise blood pressure. Known. In particular, the small amount of angiotensin converting enzyme expression can be interpreted as a low blood pressure in the body.
그러므로, 함초마늘소금은 소금 섭취에 의해 혈압이 상승하는 염민감쥐에 섭취시키더라도 혈압이 상승하지 않고 안지오텐신 전환 효소 활성도 낮아 혈압 상승 억제 효과가 있음이 확인되었다.Therefore, it was confirmed that seaweed garlic salt did not increase blood pressure and had low angiotensin converting enzyme activity even when ingested into salty rats whose blood pressure increased due to salt intake.
실시예 6. 동물실험에서 함초마늘소금의 VEGF 효소 발현 촉진과 RhoA 효소 발현 억제 효과Example 6 Inhibitory Effect of Seaweed Garlic Salt on RhoA Enzyme Expression Promotion and VEGF Enzyme Expression in Animal Experiments
체내에서 혈관내피성장인자(vascular endothelial growth factor, VEGF)는 NO 합성 효소를 발현시켜 NO 생성을 유도하는 단백질로써 혈압을 조절하는 인자들 중 하나로, 이 인자의 발현량이 많을수록 NO 생성량을 증가시켜 혈압을 낮추는 역할을 한다고 알려져 있다.The vascular endothelial growth factor (VEGF) in the body is a protein that induces NO production by expressing NO synthase and is one of the factors that regulate blood pressure. It is known to play a role.
또한, 근육조직에서 RhoA(ras homolog gene family member A)는 미오신 인산화 효소(myosin phosphatase)를 저해하여 혈관긴장도(vascular tone)를 높여 혈압을 상승시킨다고 보고된 바 있다.In addition, RhoA (ras homolog gene family member A) in muscle tissue has been reported to increase blood pressure by increasing vascular tone by inhibiting myosin phosphatase.
상기 함초마늘소금의 식이가 신장 조직에서 혈압 조절 인자인 VEGF와 RhoA의 발현량에 영향을 미치는지 여부를 생화학적 분석을 통해 조사하였다.Whether the diet of the seaweed garlic salt affected the expression levels of blood pressure regulators VEGF and RhoA in kidney tissues was investigated through biochemical analysis.
구체적으로, 상기 실시예 4에서 사육한 실험동물로부터 상기 실시예 5에서 수득한 각 식이군의 지방조직 4 g을 유리병에 넣고 1% Triton X-100, 50 mM HEPES (pH 7.4), 100 mM sodium pyrophosphate, 10 mM NF, 10 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 1 /ml pepstatin, 1/ml leupeptin, 10 mM Na3VO4 및 0.1 mg/ml aprotinin으로 구성된 homogenized buffer 2 ml를 가한 다음 즉시 Polytron(PT1200E, Kinematicca AG, Switzerland)으로 균질화시켰다. 이후, 4℃에서 2시간 동안 서서히 교반시켰다. 상기 교반시켜 수득한 균질화 용액을 4℃에서 15,000 rpm의 조건으로 20분 동안 원심분리한 다음 상층액을 수득하였다. 각 식이군의 단백질 함량은 Bradford 법으로 측정하였다.Specifically, 4 g of the adipose tissue of each dietary group obtained in Example 5 from the experimental animal bred in Example 4 was placed in a glass bottle, 1% Triton X-100, 50 mM HEPES (pH 7.4), 100 mM Add 2 ml of homogenized buffer consisting of sodium pyrophosphate, 10 mM NF, 10 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 1 / ml pepstatin, 1 / ml leupeptin, 10 mM Na 3 VO 4 and 0.1 mg / ml aprotinin, and then immediately PT1200E, Kinematicca AG, Switzerland). Thereafter, the mixture was stirred slowly at 4 ° C. for 2 hours. The homogenization solution obtained by stirring was centrifuged at 4 ° C. at 15,000 rpm for 20 minutes to obtain a supernatant. Protein content of each diet group was measured by Bradford method.
각 식이군의 동일한 단백질 용액(50 μg, 10 μL)에 2 x Trcine sample buffer(Biorad) 10 μL를 가하여 95℃에서 5 분 동안 변성(denaturation)시킨 다음 이 용액을 SDS-PAGE로 전기영동하였으며, 전개된 단백질들을 폴리비닐리텐 프로라이드 멤브레인(polyvinylidene fluoride (PVDF) membrane)으로 이동시킨 다음 이 멤브레인을 트리스 버퍼 용액과 생리식염수로 세척한 후 3% BSA가 함유된 0.05% Tween-20 (TBST) 버퍼용액으로 1시간 동안 블러킹하였다. 이어 TBST 용액으로 5 분씩 3회 반복 세척된 멤브레인을 1차 항체(Anti-VEGF와 RhoA, Santa Cruz Biotechnology, 대한민국)들이 함유된 지용성 버퍼용액(lypophilized buffer)에 넣고 상온에서 서서히 교반시키면서 반응시켰다. 상기 1차 항체 반응이 끝난 멤브레인를 TBST 용액으로 5 분씩 3회 반복 세척한 다음 이차 항체(horseradish peroxidase (HRP)-conjugated goat anti-rabbit immunoglobin G)를 가하여 상온에서 1시간 동안 반응시켰다. 이후 세척된 멤브레인은 루미놀(luminol)이 함유된 enhanced chemiluminescence(ECL) 용액과 반응시켰다. 상기 반응시킨 결과를 촬영한 사진을 도 5 및 도 6에 나타내었다.10 μL of 2 x Trcine sample buffer (Biorad) was added to the same protein solution (50 μg, 10 μL) of each diet group, denatured at 95 ° C. for 5 minutes, and the solution was electrophoresed by SDS-PAGE. The developed proteins were transferred to a polyvinylidene fluoride (PVDF) membrane, which was then washed with Tris buffer solution and saline solution, followed by 0.05% Tween-20 (TBST) buffer containing 3% BSA. Blocking for 1 hour with solution. Subsequently, the membrane washed repeatedly three times with TBST solution for 5 minutes was put in a lypophilized buffer containing primary antibodies (Anti-VEGF and RhoA, Santa Cruz Biotechnology, Korea) and reacted with gentle stirring at room temperature. After completion of the primary antibody reaction, the membrane was washed three times with TBST solution three times, and then a secondary antibody (horseradish peroxidase (HRP) -conjugated goat anti-rabbit immunoglobin G) was added and reacted at room temperature for 1 hour. The washed membrane was then reacted with an enhanced chemiluminescence (ECL) solution containing luminol. 5 and 6 show photographs of the result of the reaction.
상기 도 5에 나타낸 바와 같이, 천일염만을 식이한 천일염식이군이 가장 낮은 VEGF 발현량을 나타내었고, 함초소금식이군과 함초마늘소금식이군 모두 천일염식이군 보다 높은 발현량을 보였다. 또한, 함초소금식이군과 함초마늘소금식이군 간의 VEGF 발현량은 거의 유사하였다. VEGF는 NO synthase를 발현시켜 NO 생성을 유도하는 단백질로써 혈압을 조절하는 인자들 중 하나로, 이 인자의 발현량이 많을수록 NO 생성량을 증가시켜 혈압을 낮추는 역할을 한다고 알려져 있다. 따라서, 함초마늘소금은 천일염에 비하여 NO 생성량을 증가시켜 혈압을 낮추는 것으로 확인되었다.As shown in FIG. 5, the sun salt diet group containing only sun salt showed the lowest expression level of VEGF, and both the seaweed salt diet group and the hamcho garlic salt group showed higher expression levels than the sun salt diet group. In addition, the expression levels of VEGF between the seaweed salt diet group and the seaweed garlic salt diet group were almost similar. VEGF is a protein that induces NO production by expressing NO synthase and is one of the factors controlling blood pressure. It is known that the higher the expression level of this factor, the lower the blood pressure by increasing the NO production. Therefore, it was confirmed that seaweed garlic salt lowered blood pressure by increasing the amount of NO produced compared to sun salt.
또한, 상기 도 6에 나타낸 바와 같이, 근육이완 및 수축을 조절하는 RhoA의 발현량은 VEGF 발현량과 반대 경향을 보였다. 즉, 천일염식이군은 가장 높은 RhoA 발현량을 보였으며 함초소금과 함초마늘소금식이군들은 낮은 그 발현량을 나타냈다. 또한 두 함초마늘소금식이군이 함초소금식이군보다 낮은 RhoA 발현량을 나타내었다.In addition, as shown in FIG. 6, the expression level of RhoA, which regulates muscle relaxation and contraction, showed a tendency opposite to that of VEGF expression. That is, the sun salt group showed the highest expression level of RhoA, and the seaweed salt and seaweed garlic salt group showed the low expression level. In addition, the two seaweed garlic diet groups showed lower RhoA expression than the seaweed salt diet group.
상기와 같이, 함초마늘소금이 천일염 또는 함초소금 보다 낮은 RhoA 발현량을 나타냈다는 것은 RhoA의 발현을 저해함으로써 혈관긴장도를 낮추어 혈압 상승을 억제한 것을 의미한다. 그러므로, 함초마늘소금이 함초소금 또는 천일염 보다 더욱 혈압 상승 억제 효과가 있음을 확인할 수 있었다.As described above, that the seaweed garlic salt exhibited a lower RhoA expression level than the sun salt or seaweed salt means that the blood vessel tension was reduced by inhibiting the RhoA expression, thereby suppressing the increase in blood pressure. Therefore, it was confirmed that the seaweed garlic salt has an effect of suppressing blood pressure increase more than that of seaweed salt or sun salt.
실시예 7. 동물실험에서 함초마늘소금의 항산화 효과Example 7 Antioxidant Effect of Seaweed Garlic Salt in Animal Experiments
상기 실시예 5의 동물실험에서 얻어진 혈장에서의 지질과산화물 함량은 TBARS 법에 의해 측정하였다.Lipid peroxide content in the plasma obtained in the animal experiment of Example 5 was measured by the TBARS method.
구체적으로, TBARS 법은 혈장 0.1 mL을 20% trichloroacetic acid의 0.6 M HCl 0.5 mL와 0.67% thiobarbituric acid의 1 M NaOH용액 0.3 mL를 가하여 혼합한 다음 95℃에서 20분 동안 반응시켰다. 이 반응용액을 냉각시킨 다음 부탄올 0.8 mL로 분배하여 1500×g의 조건으로 10 분 동안 원심분리하였다. 상기 수득된 부탄올층의 흡광도는 532 nm에서 측정하였으며 이들 흡광도값은 작성된 표준용액 (malonaldehyde, MDA)의 표준곡성을 이용하여 혈장에서의 지질과산화물 함량으로 환산하였다. 상기 환산하여 얻어진 결과를 도 7에 나타내었다.Specifically, in the TBARS method, 0.1 mL of plasma was mixed with 0.5 mL of 0.6 M HCl of 20% trichloroacetic acid and 0.3 mL of 1 M NaOH solution of 0.67% thiobarbituric acid, followed by reaction at 95 ° C. for 20 minutes. The reaction solution was cooled and then partitioned into 0.8 mL of butanol and centrifuged for 10 minutes at 1500 × g. The absorbance of the obtained butanol layer was measured at 532 nm and these absorbance values were converted to lipid peroxide content in plasma using the standard curvature of prepared standard solution (malonaldehyde, MDA). The result obtained by the said conversion is shown in FIG.
상기 도 7에 나타낸 바와 같이, 혈장에서 지질과산화 산화물(malondialdehyde, MDA) 함량은 천일염식이군이 가장 높게 나타났고, 함초소금식이군과 함초마늘소금식이군은 천일염식이군에 비해 혈중 MDA 함량이 낮게 나타났으며 함초마늘소금식이군이 함초소금식이군보다 더욱 낮은 함량을 보였다.As shown in FIG. 7, the lipid peroxide oxide (malondialdehyde, MDA) content in plasma was the highest in the salt group, and the seaweed salt group and the hamcho garlic salt group had a lower MDA content in blood than the salt group. The seaweed garlic diet group showed lower contents than the seaweed salt diet group.
상기 결과에 의하면, 미네랄이 풍부한 천일염이 미네랄이 거의 없는 소금보다 산화적 스트레스를 줄일 수 있더라도 함초를 이용하여 제조된 함초소금이 더욱 산화적 스트레스를 줄여주는 것으로 판단되었다. 또한, 함초와 마늘을 혼합하여 제조된 함초마늘소금은 혈중 지질과산화물 생성을 더욱 강하게 억제하는 것으로 판단되었다. 그러므로 함초마늘소금 섭취는 체내에서 소금 섭취로부터 오는 산화적 스트레스를 줄이는데 효과가 있음을 확인하였다.According to the results, even though natural salts rich in minerals can reduce oxidative stress than salts with almost no minerals, it is determined that the saltwort salt prepared using the seaweed further reduces oxidative stress. In addition, the seaweed garlic salt prepared by mixing the seaweed and garlic was determined to more strongly inhibit the production of lipid peroxides in the blood. Therefore, the intake of seaweed garlic salt was found to be effective in reducing the oxidative stress from salt intake in the body.
본 발명은 함초와 마늘의 유효성분을 포함하는 혈압 상승 예방 조성물에 관한 것이다.The present invention relates to a blood pressure increase prevention composition comprising an active ingredient of seaweed and garlic.
본 발명자들은 부작용이 없고, 장기간 사용하여도 내성이나 안정성에 대한 문제가 대두되어지지 아니한 천연물질 유래의 항고혈압 물질을 연구하던 중, 기존 혈압상승의 원인이 되는 소금 즉, NaCl을 섭취하면서도 혈압 상승을 억제할 수 있는 경우 고혈압 환자의 식이조절에 도움이 될 수 있을 것으로 판단한 결과, 이에 대해 연구를 진행하였다. 이러한 연구 결과 함초와 마늘을 함께 이용하는 경우, 혈압상승을 억제할 수 있는 효과가 우수하다는 것으로, 상기 함초와 마늘을 이용하여 제조된 소금 대체물이 천일염 또는 함초를 이용하여 제조된 소금 대체물에 비하여 안지오텐신 전환 효소 저해능 및 실험동물에 의한 혈압상승억제능이 우수하고, 항산화능도 우수하다는 것을 확인하여, 본 발명을 완성하였다.The present inventors have no side effects, and while studying antihypertensive substances derived from natural substances, which have no problems with resistance or stability even after long-term use, while increasing the blood pressure while ingesting salt, that is, NaCl, which causes an increase in existing blood pressure The study was conducted to determine if it could help to control the diet of hypertensive patients. These results indicate that the use of hamchok and garlic together, the effect of suppressing the increase in blood pressure is excellent, the salt substitute produced by using the seaweed and garlic is angiotensin conversion compared to the salt substitute prepared using sun salt or seaweed The present invention was completed by confirming that the enzyme inhibitory ability and the blood pressure increase suppression ability by the test animal were excellent and the antioxidant activity was also excellent.
이하, 본 발명을 보다 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명에 있어서, 소금은 공업용이 아닌 식용으로 사용가능한 모든 유형의 소금을 의미하는 것으로, 천일염, 암염, 꽃소금, 구운 소금, 죽염, 정제염, 재제소금, 용융 소금, 정제소금 또는 가공소금 등을 포함한다.In the present invention, salt means all types of salt that can be used for food, not for industrial purposes, and include salt, rock salt, flower salt, roasted salt, bamboo salt, refined salt, reconstituted salt, molten salt, refined salt or processed salt, and the like. do.
본 발명에 있어서, 천일염은 바닷물 또는 해수를 저류지 또는 염전으로 유입시킨 후, 바람과 햇빛 등의 자연력을 이용하여 수분을 증발시킴으로써 바닷물을 농축시켜 만든 가공되지 않은 소금을 의미하며, 굵고 반투명한 육각형의 결정을 가지는 특징을 갖는다. 상기 천일염은 칼슘, 마그네슘, 아연, 칼륨, 철 등의 많은 미네랄(무기질)이 풍부하여 미네랄 소금이라고 한다. 특히, 우리나라에서 제조된 천일염, 구체적으로 전라남도에서 제조된 천일염은 미네랄이 풍부하여 바람직하다.In the present invention, the natural salt refers to an unprocessed salt made by concentrating seawater by evaporating water using natural forces such as wind and sunlight after introducing seawater or seawater into a reservoir or salt field, and having coarse and translucent hexagons. Has the characteristic of having a crystal. The sun salt is called mineral salt because it is rich in many minerals (minerals) such as calcium, magnesium, zinc, potassium, and iron. In particular, the natural salt produced in our country, specifically, the natural salt produced in Jeollanam-do is preferred because it is rich in minerals.
본 발명에 있어서, 함초(Salicornia herbacea L., glasswort)는 명아주과의 한해살이 초본 식물로 우리나라에서는 퉁퉁마디로도 불리어지며, 칠면초와 해홍나물 등과 함께 우리나라 서해안과 남해안 바닷가에 자생하는 염생식물 중 하나이다. 이 식물은 다른 식물과 달리 높은 염도의 해수에서도 생육이 가능하며 15% 내외의 NaCl과 함께 Ca, K, Mg, Fe, Zn 등의 미네랄 성분을 과량 함유하고 있다.In the present invention, Salicornia herbacea L., glasswort is a herbaceous perennial herbaceous herbaceous plant, which is also called as a stalk in Korea, and is one of the salt plants that grow wild on the west coast and south coast of Korea along with turkey and seaweed herbs. Unlike other plants, this plant is able to grow in high salinity seawater and contains excessive amounts of minerals such as Ca, K, Mg, Fe, and Zn along with NaCl of about 15%.
본 발명에 있어서, 마늘(Allium sativum L.)은 백합과(Lilliaceae)에 속하는 다년초 식물이며, 대표적인 Allium 속 식물이다. 상기 마늘은 식품의 풍미를 증진시키는 조미료로 널리 이용되고 있으며 항균작용, 항암 효과, 간 보호 및 간 질환 치료효과 등이 밝혀진 바 있다. 상기 마늘에 함유된 alliin(S-allyl-L-cysteinesulfoxide)이 대표적인 유효 성분으로 알려져 있다.In the present invention, garlic ( Allium sativum L.) is a perennial plant belonging to the genus Lilliaceae, is a representative Allium plant. Garlic has been widely used as a seasoning to enhance the flavor of food and has been found to be antibacterial, anti-cancer effect, liver protection and liver disease treatment effect. Alliin (S-allyl-L-cysteinesulfoxide) contained in the garlic is known as a representative active ingredient.
본 발명에 있어서, 함초마늘소금은 본 발명의 제조방법에 의하여 제조되고, 함초 및 마늘을 주 재료로 하며, 염화나트륨(NaCl)을 다량 함유하고 있어, 소금 대체물로 사용될 수 있으며, 염화나트륨 섭취에 의한 혈압의 상승을 억제할 수 있어서, 항고혈압능 즉, 고혈압 개선, 억제 또는 예방 효과가 있는 소금 대체용 식품 첨가물을 의미한다.In the present invention, the seaweed garlic salt is prepared by the manufacturing method of the present invention, and the main ingredients of seaweed and garlic, and contains a large amount of sodium chloride (NaCl), can be used as a salt substitute, blood pressure by sodium chloride intake It means that the anti-hypertensive effect, that is, a salt substitute food additive having an antihypertensive effect, suppression or prevention effect, can be suppressed.
본 발명에 있어서, 기능성 식품이란 식품에 물리적, 생화학적, 생물공학적 수법 등을 이용하여 해당 식품의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 식품군이나 식품 조성이 갖는 생체방어리듬조절, 질병방지와 회복 등에 관한 체조절기능을 생체에 대하여 충분히 발현하도록 설계하여 가공한 식품을 의미한다.In the present invention, a functional food is a biological defense rhythm control or disease prevention of a food group or a food composition that has added value to the food by using physical, biochemical, or biotechnological techniques to act and express the function of the food for a specific purpose. Means foods that have been designed and processed to fully express the gymnastic function of the body and recovery.
본 발명은 함초 및 마늘 추출물을 유효성분으로 포함하는 식품 첨가물 조성물에 관한 것이다.The present invention relates to a food additive composition comprising a hamcho and garlic extract as an active ingredient.
상기 함초 및 마늘 추출물은 추출용매를 이용한 식물 추출물일 수 있으며, 추출용매에 의해 수득된 추출물이거나 분획용매에 의해 수득된 분획물일 수 있다.The seaweed and garlic extract may be a plant extract using an extracting solvent, an extract obtained by an extracting solvent, or a fraction obtained by a fractionating solvent.
추출대상인 상기 함초는 줄기, 잎, 뿌리, 꽃 및 열매로 이루어진 군 중에서 선택된 1종 이상일 수 있으며, 바람직하게는 지상부일 수 있으며, 더욱 바람직하게는 잎 및 줄기로 이루어진 군중에서 선택된 1종 이상일 수 있다. 또한, 추출대상인 상기 마늘은 줄기, 잎, 뿌리, 꽃 및 열매로 이루어진 군 중에서 선택된 1종 이상일 수 있으며, 바람직하게는 열매일 수 있다.The extract may be at least one selected from the group consisting of stems, leaves, roots, flowers, and fruits, preferably at the ground portion, and more preferably at least one selected from the group consisting of leaves and stems. . In addition, the garlic to be extracted may be at least one selected from the group consisting of stems, leaves, roots, flowers, and fruits, and may preferably be a fruit.
상기 추출용매는 물, 50% 내지 100%의 메탄올, 에탄올 등의 탄소수 1 내지 4의 알콜, 에틸아세테이트 등의 극성용매와 헥산 또는 디클로로메탄의 비극성용매와 같은 유기용매, 이들의 혼합용매일 수 있으며, 바람직하게는 물 또는 50% 내지 100%의 메탄올, 에탄올 등의 탄소수 1 내지 4의 알콜, 더욱 바람직하게는 물일 수 있다.The extraction solvent may be water, 50% to 100% methanol, alcohol having 1 to 4 carbon atoms such as ethanol, polar solvent such as ethyl acetate, organic solvent such as a non-polar solvent of hexane or dichloromethane, mixed solvent thereof, , Preferably water or alcohol having 1 to 4 carbon atoms such as methanol, ethanol of 50% to 100%, more preferably water.
본 발명의 함초 추출물은 통상의 식물 추출물의 제조방법에 따라 제조된 것일 수 있으며, 구체적으로는 냉침추출법, 온침추출법 또는 열 추출법 등일 수 있으며, 통상의 추출기기, 초음파분쇄 추출기 또는 분획기를 이용할 수 있으며, 바람직하게는 열수 추출법일 수 있다.Hamcho extract of the present invention may be prepared according to the conventional method for producing a plant extract, specifically may be cold extraction, hot extraction or heat extraction, etc., may be used a conventional extraction device, ultrasonic grinding extractor or fractionator It may be preferably a hot water extraction method.
상기 제조된 추출물은 이후 여과하거나 농축 또는 건조과정을 수행하여 용매를 제거할 수 있으며, 여과, 농축 및 건조를 모두 수행할 수 있다. 구체적으로 상기 여과는 여과지를 이용하거나 감압여과기를 이용할 수 있으며, 상기 농축은 감압 농축기, 일예로 회전 증발기를 이용하여 감압 농축할 수 있으며, 상기 건조는 일예로 분무건조법으로 수행할 수 있다.The prepared extract can then be filtered or concentrated or dried to remove the solvent, it can be carried out both filtration, concentration and drying. Specifically, the filtration may be performed using a filter paper or a reduced pressure filter, the concentration may be concentrated under reduced pressure using a reduced pressure concentrator, for example, a rotary evaporator, and the drying may be performed by, for example, spray drying.
상기 함초 및 마늘 추출물을 유효성분으로 포함하는 식품 첨가물 조성물은 소금 대체용 식품 첨가물 조성물일 수 있다.Food additive composition comprising the extract and the garlic extract as an active ingredient may be a food additive composition for salt replacement.
구체적으로, 본 발명의 소금 대체용 식품 첨가물 조성물은 함초마늘소금일 수 있고, 바람직하게는 본 발명의 제조방법에 의해 제조된 함초마늘소금일 수 있다.Specifically, the salt substitute food additive composition of the present invention may be a seaweed garlic salt, preferably may be a seaweed garlic salt prepared by the production method of the present invention.
본 발명의 제조방법은 함초 및 마늘을 혼합하는 단계; 상기 함초 및 마늘 혼합물을 열수 추출하는 단계 및 상기 함초 및 마늘 열수 추출물을 건조하는 단계를 포함하는 함초마늘소금의 제조방법일 수 있다.The production method of the present invention comprises the steps of mixing the seaweed and garlic; It may be a method of manufacturing a seaweed garlic salt comprising the step of extracting the hot water and the mixture of the seaweed and garlic and drying the hot water extract of the seaweed and garlic.
상기 함초 및 마늘을 혼합하는 단계는 함초 및 마늘을 혼합하는 방법으로 수행할 수 있다. 상기 함초는 함초의 지상부 즉, 잎 및 줄기를 건조하고 마쇄한 것일 수 있다. 상기 마늘은 마늘의 열매 자체 또는 상기 열매의 분쇄물일 수 있다. 상기 함초 및 마늘의 혼합비는 항고혈압 즉, 혈압 억제능이라는 기능성과 식감과 향 등을 포함한 기호도를 고려하여 중량비를 기준으로 9.9:0.1(함초:마늘) 내지 7:3(함초:마늘) 또는 9.5:0.5(함초:마늘) 내지 8:2(함초:마늘) 또는 9:1(함초:마늘)의 비율로 혼합할 수 있다.Mixing the seaweed and garlic may be performed by mixing the seaweed and garlic. The grasswort may be a ground and dried leaf and stem of the grasswort and dried. The garlic may be a fruit of garlic or a pulverized product of the fruit. The mixing ratio of the seaweed and garlic is 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) or 9.5: It may be mixed in a ratio of 0.5 (seaweed: garlic) to 8: 2 (seaweed: garlic) or 9: 1 (seaweed: garlic).
상기 함초 및 마늘 혼합물을 열수 추출하는 단계는 상기 함초 마늘 혼합물에 물을 첨가하고 70 내지 200℃ 또는 100 내지 175℃ 또는 120 내지 150℃ 및 5 기압(atm) 내지 20 기압(atm) 또는 10 기압(atm) 내지 17 기압(atm) 또는 15 기압(atm)에서 1시간 내지 24시간 또는 2시간 내지 12시간 또는 4시간 내지 7시간 동안 가열하는 방법으로 수행할 수 있다. 상기 열수 추출하는 단계는 상기 방법으로 추출한 후에 수득된 조추출액을 여과하여 추출액을 얻는 과정 또는 상기 추출액을 감압 농축하여 농축액을 얻는 과정을 추가로 포함할 수 있다.The hydrothermal extraction of the mixture of seaweed and garlic may be performed by adding water to the grasswort garlic mixture and adding 70 to 200 ° C or 100 to 175 ° C or 120 to 150 ° C and 5 atm to 20 atm or 10 atm ( atm) to 17 atm or 15 atm for 1 hour to 24 hours or 2 hours to 12 hours or 4 hours to 7 hours. The extracting of hot water may further include obtaining a extract by filtering the crude extract obtained after extraction by the above method or obtaining a concentrate by concentrating the extract under reduced pressure.
상기 함초 및 마늘 열수 추출물을 건조하는 단계는 상기 함초 및 마늘 열수 추출물을 건조하는 방법으로 수행할수 있다. 상기 건조하는 방법은 상기 함초 및 마늘 열수 추출물의 수분을 제거시키는 방법일 수 있으며, 일 예로 분무건조법을 통해 분말형태로 제조하는 방법일 수 있다.Drying the seaweed and garlic hot water extract may be performed by drying the seaweed and garlic hot water extract. The drying method may be a method of removing moisture of the seaweed and garlic hot water extract, for example, may be a method of preparing in powder form through a spray drying method.
보고된 자료에 의하면, 안지오텐신 전환 효소는 부신, 혈관평활근세포, 신장, 심장 등에 존재하는 4종의 AT 수용체(AT receptor)에 작용하며, 이들은 혈관수축, 알도스테론(aldosterone)과 바스포레신(vasopressin) 방출, 세뇨관의 나트륨 흡수, 신장으로의 혈류량 감소 등을 유발함으로써 심혈관, 신장 및 중추신경 부위에 여러 가지 병변을 가져올 수 있으므로, 안지오텐신 전환 효소의 저해물질 또는 안지오텐신 전환 효소 저해제(ACE inhibitor)는 고혈압, 심장병, 동맥경화 또는 뇌출혈 등의 심혈관계 질환을 치료, 개선 또는 예방할 수 있다.Reported data show that angiotensin converting enzymes act on four types of AT receptors present in the adrenal glands, vascular smooth muscle cells, kidneys, and the heart, and these include vasoconstriction, aldosterone, and vasopressin. It can cause various lesions in the cardiovascular, renal and central nerve areas by inducing release, absorption of sodium in the tubules, and decreased blood flow to the kidneys. Therefore, inhibitors of angiotensin converting enzyme or angiotensin converting enzyme inhibitor (ACE inhibitor) It can treat, ameliorate or prevent cardiovascular diseases such as heart disease, arteriosclerosis, or cerebral hemorrhage.
본 발명에서 혈압이란 혈액이 혈관 벽에 가하는 힘을 말한다. 혈압을 읽을 때에는 수축기 혈압(최고혈압)과 확장기 혈압(최저혈압)으로 나누어서 읽는다. 수축기 혈압은 심장이 수축하면서 혈액을 내보낼 때 혈관에 가해지는 압력이고, 확장기 혈압은 심장이 확장(이완)하면서 혈액을 받아들일 때 혈관이 받는 압력이다.Blood pressure in the present invention refers to the force that blood exerts on the walls of blood vessels. When reading blood pressure, it is divided into systolic blood pressure (highest blood pressure) and diastolic blood pressure (lowest blood pressure). Systolic blood pressure is the pressure exerted on blood vessels as the heart contracts and releases blood, while diastolic blood pressure is the pressure the blood vessel receives when the heart receives blood as it expands (relaxes).
상기 고혈압이란 18세 이상의 성인에서 수축기 혈압이 140mmHg 이상이거나 확장기 혈압이 90mmHg이상인 질환으로, 원인이 발견되지 않는 경우를 본태성(일차성) 고혈압과 원인이 밝혀져 있고 이에 의해 고혈압이 발생하는 경우으로 구분되며, 전체 고혈압 환자의 약 95%는 본태성 고혈압이다. 상기 고혈압에 의해 유발되는 질병으로는 고혈압심장병(hypertensive heart disease) 등이 있다.The hypertension is a disease in which systolic blood pressure is 140 mmHg or more or diastolic blood pressure is 90 mmHg or more in adults over 18 years of age, and the cause is not found in cases of essential (primary) hypertension and the cause of which hypertension occurs. About 95% of all hypertensive patients are essential hypertension. Diseases caused by the hypertension include hypertensive heart disease (hypertensive heart disease).
상기 함초 및 마늘 추출물을 유효성분으로 포함하는 식품 첨가물 조성물 또는 본 발명의 제조방법에 의해 제조된 함초마늘소금은 안지오텐신 전환효소를 저해할 수 있고, 혈압강하능이 있으므로, 고혈압의 치료, 예방 또는 개선용 조성물로 사용될 수 있다.Food additive composition containing the seaweed and garlic extract as an active ingredient or seaweed garlic salt prepared by the manufacturing method of the present invention may inhibit angiotensin converting enzyme, and has an ability to lower blood pressure, thereby treating, preventing or improving hypertension. It can be used as a composition.
상기 고혈압은 혈관관련 질병으로, 주로 동맥의 혈압이 높은 동맥성 고혈압일 수 있다. 상기 고혈압은 동맥경화나 고혈압심장병(hypertensive heart disease) 등을 유발할 수 있다.The hypertension is a blood vessel-related disease, and may be arterial hypertension with high arterial blood pressure. The hypertension may cause arteriosclerosis or hypertensive heart disease.
또한, 안지오텐신 전환효소는 혈관과 신장의 근위세뇨관, 내피, 심장, 폐, 활성화된 대식세포, 뇌조직 등에서 발견되는 디카르복실 펩타이드(dicarboxyl peptides)의 하나로, 혈관수축, 알도스테론(aldosterone)과 바소프레신(vasopressin) 방출, 세뇨관의 나트륨 흡수 및 신장으로의 혈류량 감소 등을 유발함으로써 심혈관, 신장 및 중추신경 부위에 여러 가지 병변을 가져올 수 있는 것으로 보고되고 있다.In addition, angiotensin converting enzymes are one of the dicarboxyl peptides found in the proximal tubules of the blood vessels and kidneys, endothelial, heart, lung, activated macrophages and brain tissues. Vasopressin release, the absorption of sodium in the tubules and decreased blood flow to the kidney have been reported to lead to various lesions in the cardiovascular, renal and central nervous areas.
따라서, 상기 안지오텐신 전환 효소의 저해 물질 또는 안지오텐신 전환효소 저해제(ACE inhibitor)는 고혈압, 심장병, 동맥경화 또는 뇌출혈 등의 심혈관계 질환이나 신장병 등을 치료 또는 예방할 수 있는 것으로 보고되고 있으며, 구체적으로 임상연구 및 임상실험 결과에 의하면, 안지오텐신 전환효소 저해제는 고혈압, 만성신장병, 동맥경화, 심장발작과 그로 인한 사망 등을 효과적으로 감소시킬 수 있는 것으로 보고되고 있다.Therefore, the angiotensin converting enzyme inhibitor or angiotensin converting enzyme inhibitor (ACE inhibitor) is reported to be able to treat or prevent cardiovascular diseases such as hypertension, heart disease, arteriosclerosis, or cerebral hemorrhage or kidney disease, and specifically, clinical studies In clinical trials, angiotensin converting enzyme inhibitors have been reported to effectively reduce hypertension, chronic kidney disease, atherosclerosis, heart attacks and death.
상기 함초 및 마늘 추출물을 유효성분으로 포함하는 식품 첨가물 조성물 또는 본 발명의 제조방법에 의해 제조된 함초마늘소금은 안지오텐신 전환효소를 유효하게 저해하고, 동물 실험을 통하여 확인한 결과 혈압강하능이 있으므로, 고혈압 및 심장병, 동맥경화 또는 뇌출혈 등의 심혈관계 질환에 치료, 예방 또는 개선 효과가 있다.Food additive composition containing the seaweed and garlic extract as an active ingredient or seaweed garlic salt prepared by the manufacturing method of the present invention effectively inhibits angiotensin converting enzyme, and as a result of animal experiments confirmed that blood pressure lowering ability, hypertension and It is effective in treating, preventing or ameliorating cardiovascular diseases such as heart disease, arteriosclerosis, or cerebral hemorrhage.
상기 함초 및 마늘 추출물을 유효성분으로 포함하는 식품 첨가물 조성물, 구체적으로 상기 함초 및 마늘 추출물을 유효성분으로 포함하는 소금 대체용 식품 첨가물 조성물은 안지오텐신 전환효소를 유효하게 저해하고, 동물 실험을 통하여 확인한 결과 혈압강하능이 있으며, 항산화능을 가지므로, 항고혈압능 즉, 고혈압 개선, 예방 또는 억제 효과를 가진다.Food additive composition comprising the extract of the seaweed and garlic as an active ingredient, in particular the salt substitute food additive composition containing the extract as an active ingredient effectively inhibits angiotensin converting enzyme, and confirmed through animal experiments It has an antihypertensive ability and an antioxidant ability, and thus has an antihypertensive effect, that is, an antihypertensive effect, a prophylactic or inhibitory effect.
본 발명의 함초 및 마늘 추출물을 유효성분으로 포함하는 식품 첨가물 조성물은 조성물 총 중량에 대하여 상기 유효성분을 0.001 내지 99.99중량%, 바람직하게는 0.1 내지 99 중량%로 포함할 수 있다.Food additive composition comprising the extract and the garlic extract of the present invention as an active ingredient may comprise the active ingredient in an amount of 0.001 to 99.99% by weight, preferably 0.1 to 99% by weight based on the total weight of the composition.
상기 식품이란 영양소를 한 가지 또는 그 이상 함유하고 있는 천연물 또는 가공품을 의미하며, 바람직하게는 어느 정도의 가공 공정을 거쳐 직접 먹을 수 있는 상태가 된 것을 의미한다.The food means a natural product or a processed product containing one or more nutrients, and preferably means a state in which it can be directly eaten through some processing process.
상기 식품 첨가물(food additive)이란 식품의 제조가공 또는 보존을 목적으로 식품에 첨가 또는 혼합하여 식품의 품질을 향상시키는 물질을 의미하고, 식품의 제조, 가공 또는 저장 과정에서 원재료 또는 주재료 이외에 식품에 사용되는 물질을 포함하며, 식품위생법 제2조 제3항에서 규정하는 첨가물을 포함하는 개념이다.The food additive means a substance which improves the quality of the food by adding or mixing the food for the purpose of manufacturing, processing, or preserving the food, and used for food in addition to the raw materials or the main ingredient in the manufacturing, processing or storage of the food. It is a concept that includes the substance to be added and the additives prescribed in Article 2 (3) of the Food Sanitation Act.
상기 식품 첨가물은 음식에 짠맛을 부여하기 위한 목적으로 사용될 수 있으므로, 이러한 의미에서 소금, 간장 또는 된장 등을 대체하기 위한 조미료로 사용될 수 있고, 소금 섭취에 의한 당뇨 유발 효과 등을 억제, 개선 또는 예방하기 위한 것이므로, 바람직하게는 소금 대체용 식품 첨가물일 수 있다.Since the food additive may be used for the purpose of imparting saltiness to food, it may be used as a seasoning for replacing salt, soy sauce or miso in this sense, and to suppress, improve or prevent diabetes-induced effects such as salt intake. Since it is intended to be, it may preferably be a salt substitute food additive.
이러한 의미에서 상기 식품 첨가물은 소금 대체용 식품 첨가물일 수 있다.In this sense, the food additive may be a salt substitute food additive.
상기 식품 첨가물은 소금과 같이 짠맛을 부여하면서도, 안지오텐신 전환효소 저해능 및 혈압강하능이 인정되므로, 이러한 측면에서 상기 식품 첨가물은 기능성 식품에 해당될 수 있다.While the food additives impart salty taste, such as salt, angiotensin converting enzyme inhibitory ability and blood pressure lowering ability are recognized, and in this aspect, the food additives may correspond to functional foods.
상기 식품 첨가물은 추가로 식품학적으로 허용 가능한 식품 보조 첨가제를 더욱 포함할 수 있으며, 식품 첨가물 또는 기능성 식품의 제조에 통상적으로 사용되는 적절한 담체, 부형제 및 희석제를 더욱 포함할 수 있다. 상기 담체, 부형제 및 희석제는 독립적으로 또는 조합하여 사용할 수 있다. 이러한 담체, 부형제 및 희석제 등 추가적으로 포함되는 보조 첨가제의 비율은 그렇게 중요하지 않지만, 본 발명의 유효성분 100 중량부 당 0 내지 20000 중량부 범위에서 선택될 수 있다.The food additive may further include food acceptable food additives, and may further include appropriate carriers, excipients and diluents commonly used in the preparation of food additives or functional foods. The carriers, excipients and diluents can be used independently or in combination. The proportion of auxiliary additives additionally included such carriers, excipients and diluents is not so critical, but may be selected from 0 to 20000 parts by weight per 100 parts by weight of the active ingredient of the present invention.
본 발명의 조성물은 소금을 포함하고 있음에도 불구하고, 기존에 혈압상승 즉, 고혈압을 유발할 수 있는 것으로 확인된 식용으로 주로 사용되는 정제염 등과 달리 안지오텐신 전환 효소를 저해하고, 실험동물에 의해 확인한 결과 혈압상승 억제능이 확인되어, 고혈압 질환을 갖는 환자 또는 이러한 위험성이 있는 개체에 있어서 유용하게 사용될 수 있고, 특히 상기 환자 또는 상기 개체가 섭취하는 음식에 짠맛을 부여하기 위한 목적으로 유용하게 사용될 수 있을 것으로 판단된다.Despite the salt composition, the composition of the present invention inhibits angiotensin-converting enzymes unlike the purified salts that are mainly used for edible blood pressure, that is, conventionally found to be capable of causing high blood pressure, and confirmed by experimental animals. It has been confirmed that the inhibitory ability can be useful in patients with hypertension or in individuals at risk of these diseases, and particularly, for the purpose of imparting salty taste to the patient or the food ingested by the individual. .
또한, 본 발명은 항고혈압 효과 즉, 고혈압 개선, 예방 또는 억제 효과가 있는 함초마늘소금의 제조방법을 제공한다.In addition, the present invention provides a method for producing a seaweed garlic salt that has an antihypertensive effect, that is, hypertension improvement, prevention or inhibition.
본 발명의 제조방법은 함초 및 마늘을 혼합하는 단계; 상기 함초 및 마늘 혼합물을 열수 추출하는 단계 및 상기 함초 및 마늘 열수 추출물을 건조하는 단계를 포함하는 함초마늘소금의 제조방법일 수 있다.The production method of the present invention comprises the steps of mixing the seaweed and garlic; It may be a method of manufacturing a seaweed garlic salt comprising the step of extracting the hot water and the mixture of the seaweed and garlic and drying the hot water extract of the seaweed and garlic.
상기 함초 및 마늘을 혼합하는 단계는 함초 및 마늘을 혼합하는 방법으로 수행할 수 있다. 상기 함초는 함초의 지상부 즉, 잎 및 줄기를 건조하고 마쇄한 것일 수 있다. 상기 마늘은 마늘의 열매 자체 또는 상기 열매의 분쇄물일 수 있다. 상기 함초 및 마늘의 혼합비는 항고혈압 즉, 혈압 억제능이라는 기능성과 식감과 향 등을 포함한 기호도를 고려하여 중량비를 기준으로 9.9:0.1(함초:마늘) 내지 7:3(함초:마늘) 또는 9.5:0.5(함초:마늘) 내지 8:2(함초:마늘) 또는 9:1(함초:마늘)의 비율로 혼합할 수 있다.Mixing the seaweed and garlic may be performed by mixing the seaweed and garlic. The grasswort may be a ground and dried leaf and stem of the grasswort and dried. The garlic may be a fruit of garlic or a pulverized product of the fruit. The mixing ratio of the seaweed and garlic is 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) or 9.5: based on the weight ratio in consideration of the anti-hypertension, that is, the function of inhibiting blood pressure and the preference including texture and flavor. It may be mixed in a ratio of 0.5 (seaweed: garlic) to 8: 2 (seaweed: garlic) or 9: 1 (seaweed: garlic).
상기 함초 및 마늘 혼합물을 열수 추출하는 단계는 상기 함초 마늘 혼합물에 물을 첨가하고 70 내지 200℃ 또는 100 내지 175℃ 또는 120 내지 150℃ 및 5 기압(atm) 내지 20 기압(atm) 또는 10 기압(atm) 내지 17 기압(atm) 또는 15 기압(atm)에서 1시간 내지 24시간 또는 2시간 내지 12시간 또는 4시간 내지 7시간 동안 가열하는 방법으로 수행할 수 있다. 상기 열수 추출하는 단계는 상기 방법으로 추출한 후에 수득된 조추출액을 여과하여 추출액을 얻는 과정 또는 상기 추출액을 감압 농축하여 농축액을 얻는 과정을 추가로 포함할 수 있다.The hydrothermal extraction of the mixture of seaweed and garlic may be performed by adding water to the grasswort garlic mixture and adding 70 to 200 ° C or 100 to 175 ° C or 120 to 150 ° C and 5 atm to 20 atm or 10 atm ( atm) to 17 atm or 15 atm for 1 hour to 24 hours or 2 hours to 12 hours or 4 hours to 7 hours. The extracting of hot water may further include obtaining a extract by filtering the crude extract obtained after extraction by the above method or obtaining a concentrate by concentrating the extract under reduced pressure.
상기 함초 및 마늘 열수 추출물을 건조하는 단계는 상기 함초 및 마늘 열수 추출물을 건조하는 방법으로 수행할수 있다. 상기 건조하는 방법은 상기 함초 및 마늘 열수 추출물의 수분을 제거시키는 방법일 수 있으며, 일 예로 분무건조법을 통해 분말형태로 제조하는 방법일 수 있다.Drying the seaweed and garlic hot water extract may be performed by drying the seaweed and garlic hot water extract. The drying method may be a method of removing moisture of the seaweed and garlic hot water extract, for example, may be a method of preparing in powder form through a spray drying method.
본 발명의 함초와 마늘을 이용하여 제조된 조성물은 일반 소금과 달리 항고혈압 활성을 갖는 것으로 알려진 천일염과 동등한 NaCl 함량을 가지면서도 우수한 혈압상승억제 효과를 가질 뿐만 아니라, 일반적으로 식용하는 함초와 마늘을 이용하는 것이어서 부작용 등이 문제되지 아니하므로, 산업적으로 그 효과가 매우 크다 할 것이다.The composition prepared by using the seaweed and garlic of the present invention, unlike ordinary salts, has a NaCl content equivalent to that of sun salt, which is known to have antihypertensive activity, but also has an excellent blood pressure suppression effect, and commonly used edible seaweed and garlic Since the side effects are not a problem because it is used, the effect will be very large industrially.
Claims (3)
- 함초 및 마늘 혼합물의 열수 추출물을 유효성분으로 포함하는 고혈압 억제 또는 예방 효과가 있는 소금 대체용 식품 첨가물 조성물.A food substitute composition for salt replacement having a hypertension suppressing or preventing effect, comprising a hot water extract of a mixture of seaweed and garlic as an active ingredient.
- 제1항에 있어서,The method of claim 1,상기 소금 대체용 식품 첨가물 조성물은 함초의 잎 및 줄기를 건조하고 마쇄한 함초 마쇄물 및 마늘을 중량을 기준으로 9.9:0.1(함초:마늘) 내지 7:3(함초:마늘)의 함량비로 혼합하는 단계; 상기 함초 및 마늘 혼합물을 100 내지 175℃ 및 10 기압(atm) 내지 17 기압(atm)의 조건에서 2시간 내지 12시간 동안 열수 추출하여 함초 및 마늘 열수 추출물을 제조하는 단계 및 상기 함초 및 마늘 열수 추출물을 분무건조하여 건조하는 단계를 포함하는 방법으로 제조한 것인 고혈압 억제 또는 예방 효과가 있는 소금 대체용 식품 첨가물 조성물.The salt substitute food additive composition is to dry the leaves and stems of the seaweed and mix the ground crushed seaweed grinding and garlic based on the weight ratio of 9.9: 0.1 (seaweed: garlic) to 7: 3 (seaweed: garlic) step; Hot water extraction for 2 to 12 hours at 100 to 175 ℃ and 10 atm (atm) to 17 atm (atm) of the mixture of the seaweed and garlic mixture to prepare a hot water extract and a garlic and hot water extract A salt substitute food additive composition having a high blood pressure inhibiting or preventing effect, which is prepared by a method comprising spray drying to dry.
- 함초의 잎 및 줄기를 건조하고 마쇄한 함초 마쇄물 및 마늘을 중량을 기준으로 9:1(함초:마늘)로 혼합하는 단계; 상기 함초 및 마늘 혼합물을 130℃ 및 15기압(atm)의 조건에서 5시간 동안 열수 추출하여 함초 및 마늘 열수 추출물을 제조하는 단계 및 상기 함초 및 마늘 열수 추출물을 분무건조하여 건조하는 단계Mixing the leaves and stems of the seaweeds with dry and ground seaweed ground powder and garlic in a weight ratio of 9: 1 (seaweed: garlic) by weight; Hot water extraction for 5 hours at 130 ℃ and 15 atm (atm) of the mixture to prepare the seaweed and garlic hot water extract and the step of spray drying the seaweed and garlic hot water extract to dry를 포함하는 혈압상승 억제 또는 예방 효과가 있는 함초마늘소금의 제조방법.Method of producing a seaweed garlic salt having a blood pressure increase suppression or prevention effect.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110111816A KR20130047043A (en) | 2011-10-31 | 2011-10-31 | An composition for preventing gastric ulcer comprising purple bamboo salt |
KR10-2011-0111816 | 2011-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013066050A1 true WO2013066050A1 (en) | 2013-05-10 |
Family
ID=48192342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2012/009072 WO2013066050A1 (en) | 2011-10-31 | 2012-10-31 | Composition for preventing raised blood pressure comprising salicornia herbacea and garlic, and production method therefor |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20130047043A (en) |
WO (1) | WO2013066050A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202015106158U1 (en) | 2015-11-13 | 2016-02-01 | Valiantsina Reis | Garlic paste |
DE102015222473A1 (en) | 2015-11-13 | 2017-05-18 | Valiantsina Reis | Garlic paste, process for their preparation and their use |
CN111944009A (en) * | 2020-08-14 | 2020-11-17 | 盐城工学院 | Preparation method and application of salicornia bigelovii antihypertensive peptide |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010083036A (en) * | 2000-02-22 | 2001-08-31 | 김원대 | Plant salt of preparation method and Plant salt |
KR20030008712A (en) * | 2001-07-19 | 2003-01-29 | (주)소금나라 | Novel Salt Impregnated with Concentrated Extract of Halophilous Plant and Method for Preparing the Same |
KR20040047487A (en) * | 2002-11-28 | 2004-06-05 | 김선재 | Preparation of Mineral and Salt from Sea-weed |
KR20060130978A (en) * | 2005-06-14 | 2006-12-20 | 우송대학교 산학협력단 | Plant extract powder mixtures for hypertension patient with salty taste |
KR100784229B1 (en) * | 2007-05-17 | 2007-12-11 | 주식회사 파이토코 | Salicornia herbacea-derived salt and its production process |
KR20090129765A (en) * | 2008-06-13 | 2009-12-17 | 안재식 | Mineral fortified salt and manufacturing method thereof |
-
2011
- 2011-10-31 KR KR1020110111816A patent/KR20130047043A/en not_active Application Discontinuation
-
2012
- 2012-10-31 WO PCT/KR2012/009072 patent/WO2013066050A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010083036A (en) * | 2000-02-22 | 2001-08-31 | 김원대 | Plant salt of preparation method and Plant salt |
KR20030008712A (en) * | 2001-07-19 | 2003-01-29 | (주)소금나라 | Novel Salt Impregnated with Concentrated Extract of Halophilous Plant and Method for Preparing the Same |
KR20040047487A (en) * | 2002-11-28 | 2004-06-05 | 김선재 | Preparation of Mineral and Salt from Sea-weed |
KR20060130978A (en) * | 2005-06-14 | 2006-12-20 | 우송대학교 산학협력단 | Plant extract powder mixtures for hypertension patient with salty taste |
KR100784229B1 (en) * | 2007-05-17 | 2007-12-11 | 주식회사 파이토코 | Salicornia herbacea-derived salt and its production process |
KR20090129765A (en) * | 2008-06-13 | 2009-12-17 | 안재식 | Mineral fortified salt and manufacturing method thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE202015106158U1 (en) | 2015-11-13 | 2016-02-01 | Valiantsina Reis | Garlic paste |
DE102015222473A1 (en) | 2015-11-13 | 2017-05-18 | Valiantsina Reis | Garlic paste, process for their preparation and their use |
CN111944009A (en) * | 2020-08-14 | 2020-11-17 | 盐城工学院 | Preparation method and application of salicornia bigelovii antihypertensive peptide |
CN111944009B (en) * | 2020-08-14 | 2022-09-02 | 盐城工学院 | Preparation method and application of salicornia bigelovii antihypertensive peptide |
Also Published As
Publication number | Publication date |
---|---|
KR20130047043A (en) | 2013-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101651907B1 (en) | Composition for Prevention or Treatment of Obesity Comprising Tenebrio molitor larva extract or Tenebrio molitor larva suspension | |
US20170106035A1 (en) | Composition for preventing and treating non-alcoholic fatty liver diseases | |
WO2006073265A9 (en) | Composition comprising an extract of gramineae plant for the prevention and treatment of ischemic diseases and degenerative brain diseases and the use thereof | |
US20110038959A1 (en) | Plant-origin drug for preventing or improving hyperuricemia | |
JP2016003225A (en) | Dipeptidyl peptidase 4 inhibitor | |
KR101600940B1 (en) | Compositon for preventing and treating diabetes and hypertension comprising fermented broth of plant-originated Lactic acid bacteria | |
JP2007306898A (en) | Functional food using cordyceps sinensis (berkeley) saccardo, and method for producing the same | |
WO2013066050A1 (en) | Composition for preventing raised blood pressure comprising salicornia herbacea and garlic, and production method therefor | |
KR20050054009A (en) | Composition comprising the extract of cucurbita spe. or purified extract isolated therefrom having anti-adipogenic and anti-obesity activity | |
WO2016190566A9 (en) | Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient | |
KR101446528B1 (en) | Vinegar Composition Fermented with Black Garlic and Preparation Method Thereof | |
KR20130058434A (en) | A composition comprising extract of cordyceps militaris for prevention and treatment of non-alcoholic steatosis | |
KR20150053321A (en) | Anti obesity Composition comprising anthocyanin originated from black bean peels as an active ingredient | |
KR20180098888A (en) | Composition for increasing immunity having extract of peanut sprouts extract as active component | |
EP2240191A2 (en) | Composition comprising the extracts of lysimachia clethroides for prevention and treatment of cardiovascular diseases | |
KR20130083427A (en) | Composition for preventing, improving, or treating a disease controlled by ppar action | |
US20170035828A1 (en) | Composition containing scutellaria alpina extract | |
US20240115644A1 (en) | Composition for preventing, improving or treating gastritis or peptic ulcer comprising extract of cinnamomum cassia, fraction of said extract, isolate of said fraction or compounds isolated therefrom | |
JP2014040480A (en) | Xanthine oxidase inhibitor and uric acid production inhibitor | |
CN111944009B (en) | Preparation method and application of salicornia bigelovii antihypertensive peptide | |
KR100660175B1 (en) | Composition in drink to get rid of hangover | |
KR101257329B1 (en) | Composition for treating or preventing obesity containing stichpus japonicus extract | |
KR102607239B1 (en) | Composition comprising as an active ingredient a sweet potato extract | |
KR20150091770A (en) | Composition for treating or preventing obesity containing caulerpa okamurai | |
KR100832520B1 (en) | A composition for the treatment or prevention of osteoporosis comprising an extract of capsosiphon fulvecense |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12846620 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12846620 Country of ref document: EP Kind code of ref document: A1 |